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Abstract 
 
The first ionic liquid (IL) was synthetized in 1914. Since then 
the interest in this field is in exponential growth. These 
compounds are present in diverse areas of science such as 
electrochemistry or biomedical research. 
In this work fluorinated ionic liquids (FILs), a specific family 
of ionic liquids, where studied in order to evaluate their 
capacity to replace partial or totally perfluorocarbons (PFCs) 
in PFCs emulsions, actually used as artificial blood 
substitutes, also known as oxygen therapeutics. With this aim 
in mind, the thermophysical characterization was performed 
as also citotoxicity assays and octanol – water partition 
coefficients. This last parameter is used to understand the 
potential of these FILs to penetrate cell membranes. 
In last years a new third generation of ionic liquids appeared 
which is directly linked to pharmaceutical research. A lot of 
studies were done in order to develop a new formulation that 
conjugates diverse active pharmaceutical ingredients (APIs) 
with ILs. This conjugation was made to avoid some 
disadvantages related to the parent API, particulary poor 
water solubility. The purpose of this work is to compare the 
thermical properties, toxicity and partition properties of this 
new formulation API-ILs with the parent API. These novels 
ILs are based on cholinium as a benign cation combined with 
three different APIs like anions. 
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Palavras - chave 
 
Liquidos Iónicos, Substitutos artificiais do sangue, Príncipios 
Activos Farmacêuticos, Caracterização Termofísica, 
Toxicidade, Coeficientes de Partição Octanol-Água  
Resumo 
 
Em 1914 foi sintetizado o primeiro líquido iónico (LI),e desde 
então o interesse nesta área tem vindo a aumentar 
exponencialmente. São diversos os ramos de utilização destes 
compostos, desde a electroquímica até às aplicações 
biomédicas. 
Uma família específica de liquidos iónicos, os líquidos iónicos 
fluorados (LIFs) são estudados neste trabalho de modo a que 
possam vir a substituir parcial ou totalmente os 
perfluorocarbonetos (PFCs) das emulsões de PFCs, 
actualmente utilizadas como subsitutos artificiais do sangue, e 
também designadas de terapêuticas de oxigénio. Com este 
objectivo efectuou-se a avaliação termofísica de diversos FILs, 
a toxicidade, assim como o estudo da sua partição no modelo 
octanol-água, que ajuda a perceber o potencial dos LIFs em 
permear as membranas celulares. 
Ao londo dos anos o estudo dos LIs tem vindo a passar por 
diversas fases, sendo a última chamada de 3ª geração, a que 
estuda a sua aplicação directa na indústria farmacêutica, de 
modo a contornar determinados problemas, como a pouca 
solubilidade de muitos príncipios activos farmacêuticos (PAFs) 
De modo a contornar este e outros problemas, vários têm sido 
os estudos que formulam novos príncipios activos 
farmacêuticos em conjunto com liquidos iónicos. O objectivo 
deste trabalho visa comparar as propriedades térmicas, a 
toxicidade e a partição destes novos compostos com o príncipio 
activo farmacêutico original. Sendo estas formulações 
compostas por um catião de origem benigna, a colina, e por 
diversos PAFs, como aniões.  
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1.1 General Context  
The unique chemical and physical properties of ionic liquids (ILs) allow a great 
variety of applications, in areas like chemistry, biotechnology and medical industry 
(Florindo et al. 2013). The focus of this work is the application of ILs in biomedical 
research, particularly in the development of a new generation of artificial blood 
substitutes based on fluorinated ionic liquids (FILs). Furthermore, the development of 
cholinium-based ILs with pharmaceutically active anion was also studied. 
Human blood substitutes, also known as oxygen therapeutics had been in 
development since the 1990s. This interest emerges after human immunodeficiency 
virus (HIV) appears (Chang 2003).However, the fear of a contaminated blood donor is 
just one of the reasons to advance the studies in this area. Every day medical 
community had to replace a huge quantity of blood loss during surgery or following 
trauma. Furthermore, procedures like angioplasty and chemotherapy in cancer treatment 
require the presence of blood like adjuncts. A lot of time is wasted for the study of 
cross-match blood for donor–recipient compatibility, and for some critical situations it 
could be an enormous disadvantage. In order to avoid some side effects, the evaluation 
of minimal infectious risks or concerns about immunogenicity is essential. However, 
this evaluation increases the costs of blood transfusions (Riess 2001). Also ethical 
issues turn this scientific research very attractive, once that some religions refuse red 
blood cells transfusion (Lowe 1999; Stollings and Oyen 2006). 
Actually, there are two approaches for research in artificial blood substitutes for. 
The first one is based on haemoglobin, including products of recombinant technology, 
and the second are emulsions of inert compounds, called perfluorochemicals (PFCs), 
often described simply as fluorocarbons(Lowe 1999). Emulsions based on PFCs are 
now the preferred artificial blood candidates.  
With this project the thermophysical characterization, toxicity and partition coefficient 
of FILs were evaluated. This study was carried out in order to select the best FIL to 
partial or totally replace the PFCs in emulsion used nowadays for oxygen therapeutics. 
This substitution is linked to several advantages, such as enhancement of respiratory gas 
solubility, emulsion stability and lowering of vapour pressure. 
As mentioned above, the unique characteristics of ILs make them very useful in 
different areas of interest. Pharmaceutical industry is one of them, where the design of 
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compounds with ILs and active pharmaceutical ingredients (APIs) allow the balance 
between the chemical desired effect, the physical properties (required for manufacturing 
and transport procedures), the chemical stability, the solubility and the bioavailability of 
the final product (Florindo et al. 2013). Some studies report the capacity of ILs to 
increase the solubility of poorly soluble APIs and the potential for their application in 
drug delivery platforms (Mizuuchi et al. 2008; Moniruzzaman, Kamiya, and Goto 
2010). More recently some groups develop a new abroad where ILs are themselves the 
APIs (Ferraz et al. 2011; Hough et al. 2007) 
The application of ILs in pharmaceutical industry could overcome some 
problems during drug development process, related to the poor water solubility and 
bioavailability of mostly APIs. Elimination of polymorphisms, a big problem in the 
pharmaceutical industry can also be achieved with this approach (Hough et al. 2007; 
Rogers and Seddon 2003). 
The other important goal of this work is the development of novel API-ILs 
compounds, with the combination of cholinium cation, classified as Vitamin B4, with 
different APIs (nalidixic acid, niflumic acid and pyrazinoic acid). Cholinium is an 
essential nutrient, common in many functions of organism. Their biocompatibility 
makes them a very attractive cation for biomedical applications. 
After measurements of thermal properties, cytotoxicity and partition properties, 
a complete analysis of the benefits of this novel API-ILs design comparatively to the 
classical API model were performed. 
The results obtained of this work represent a big step in ionic liquid community, 
due to the great possibilities emerging in medical research using ionic liquids. 
 
 
1.2 Artificial blood substitutes as oxygen therapeutics 
Sometimes the designation of “blood substitute” is miss understood once that these 
compounds do not replace all of blood functions. Artificial blood substitutes are only 
responsible for transport oxygen to cells and carbon dioxide from cells to lungs during a 
limited period of time (Lowe 1999). Functions related to immunity, coagulation and 
metabolic regulation are not supply for these chemicals (Riess 2001).  
The development of these artificial blood substitutes follow two different 
approaches take into account the transport mechanism. As was mentioned above, there 
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are oxygen carriers based on haemoglobin (including products of recombinant 
technology) and in this case, the oxygen is chemically linked to carrier. Otherwise, for 
PFCs-emulsions, the oxygen is physically dissolved in carrier (Riess 2001). Both 
haemoglobin and PFCs-emulsion for artificial blood substitutes are illustrated in Figure 
1.1  
 
 
 
 
 
 
 
 
 
 
Haemoglobin-based oxygen therapeutics had a structure identical to 
haemoglobin and could derive from human, animal or genetic modified microorganisms 
and plants (Lowe 1999; Stollings and Oyen 2006). This last class presents some 
advantages related to the absence of virus and residual red cells contaminants. Through 
recombinant technology a lot of alterations can be done in order to modulate the desire 
characteristics (Lowe 1999) and the final product could be available in form of solutions 
and liposomes (Riess 2001).However, there are a lot of clinical implications in the use 
of these substitutes, like hypertension, esophageal dysmotility and abdominal 
discomfort. 
Perfluorinated compounds, fluorine-substituted hydrocarbons, are defined as inert 
organic materials that can dissolve a large volume of non-polar gases. The solubility of 
respiratory gases in PFCs tends to increase with the increment of fluorine atoms. In 
PFCs-emulsions, oxygen had solubility greater than in water or blood plasma, once that 
the dissolution process of oxygen in this systems is a simple passive process where gas 
molecules occupy the free cavities of PFCs-emulsions (Lowe 1999; Pereiro et al. 2013). 
Fluorocarbons fill the gaps in ischemic microcirculation, supplying oxygenation and 
reinstituting aerobic metabolism(Faithfull 1992). PFCs are intravascular administrated 
in the form of emulsions, due to their immiscibility in aqueous systems, and are coated 
Figure 1.1– Representation of haemoglobin and PFCs emulsion blood 
substitutes (available in: http://muslimlifemalaysia.blogspot.pt) 
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with a surfactant that serves to emulsify and stabilize the system. The most common 
surfactant used in this case is egg yolk phospholips (EYP) (Chang 2003). Recently, it 
had been discovered that some perfluorocarbons are excreted by lungs and skin in a few 
days, with no problems to organism(Clark 1973). 
Between 1989 and 1990, the first oxygen carrier based on PFCs-emulsion had 
approval for commercialization by United States Food and Drug Administration (FDA). 
This first oxygen carrier, Fluosol, was used to treat percutaneous transluminal coronary 
artery ballon angioplasty(Lowe 1994, 1997). However, these first generations of oxygen 
carriers were not very useful for medical community once that the storage and efficacy 
of these products were redundant in comparison to the new developed technical in 
angioplasty. Also some side effects were reported and the product was removed from 
market (Lowe 1999). 
With regard to develop PFCs-emulsion with highly biocompatibility, excretion 
properties, more stability (through the use of surfactants and perfluorinated stabilizers) 
and more oxygen carrying capacity, a second generation of PFCs was developed. In this 
second phase of studies, the physico-chemical properties of emulsions in general, and 
surfactants and stabilizers in particular, were better evaluated. One of the major 
problems in increasing the oxygen carrying potential was the high viscosity of the 
emulsions which is a handicap for their use in vasculature (Chang 2003). Some PFCs-
emulsions from second generation, mainly constituted of perflurobron or 
perfluorodecalin (Oxigent and Oxyfluor, as example) shown to be much better than the 
first generation. These products offer a lot of advantages comparatively whit the first 
ones. There were less sensitivity to manufacturing process and storage and showed a 
viscosity closed to the blood). 
Nowadays, a lot of these PFCs-emulsions are in clinical trials, and other 
biomedical applications for PFCs-emulsion are also in study such as anti-cancer agents, 
diagnostic imaging agents, ophthalmologic agents, among others (Faithfull 1992). 
 
1.3 Active Pharmaceutical Ingredients 
Accordingly to World Health Organization (WHO), active pharmaceutical 
ingredient (API) is a substance used in a finished pharmaceutical product (FPP) with 
chemical structure known, intended to furnish pharmacological activity or to otherwise 
have direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, 
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or to have direct effect in restoring, correcting or modifying physiological functions in 
human beings (World Health Organization 2011). The pharmaceutical products could 
be administrated in form of tablets, capsules, emulsion, creams and other ones. 
In the past years, the growing of pharmaceutical industry is dependent of several 
issues. There are more demanding regulatory requirements and more time is needed for 
research and development. With all of these barriers, the development costs of a new 
medical product are increasing(Paul et al. 2010). 
Pharmaceutical industry identify that 40% of the major problems in drug 
development are connected to poor water solubility of APIs. This factor could shelve or 
invalidate the development of several new pharmaceutical candidates. Poor aqueous 
solubility of orally administrated drugs leads to low dissolution rate and low 
bioavailability. This last property refers to the extent and rate at APIs entry in the 
systemic circulation and thus access the site of action. Bioavailability depends of the 
compound solubility in water and their capacity to cross cellular membranes(Araújo et 
al. 2014a; Florindo et al. 2013). This property could be determined by the properties of 
the dosage form which depends partly on its design and manufacture. A large amount of 
compound is required for poor aqueous soluble APIs to reach the therapeutic range 
concentrations. The consequences of this dose escalation are the topical toxicity in the 
gastrointestinal tract after oral administration, as also the increasing of manufacturing 
costs(Araújo et al. 2014b). 
Almost all pharmaceutical products are marketed in salts form. The salt 
formation is a very important procedure in drug development once that could improve 
some properties of the original compound like solubility, dissolution rate, 
hygroscopicity, stability, impurity profiles and particle characteristics. The most 
common cation present in this process is sodium ion, while the most usual anion is 
chloride (Kumar and Malhotra 2010) 
Actually mostly administration of APIs is through solid, primarily crystalline 
forms. This formulation is the elected by reason of purity, thermal stability, 
manufacturability and ease of administration. However, there are some disadvantages 
related to these solid forms which show low solubility and low bioavailability, 
especially for crystalline solids, polymorphic conversion and tendency of amorphous 
forms to spontaneously crystallize. All of these structural alterations could affect the 
solubility, chemical and physical stability, dissolution rate and bioavailability of the 
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compound. These differences between crystal forms of the same compound create 
changes in biopharmaceutical properties, like bioavailability, leading to divergences in 
pharmaceutical efficacy (Hough et al. 2007). In order to avoid these disadvantages, 
some liquid formulations had been in development, like API-ILs and eutectic mixtures. 
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1.4 Ionic Liquids 
The concept of Ionic Liquid is used to define salts entirely constituted of ions, an 
organic cation and an organic or inorganic anion (most commonly families of cations 
and anions are shown in Figure 1.2 and Figure 1.3, respectively) (Plechkova and 
Seddon 2008). These compounds have a melting temperature bellow 100ºC, due to their 
asymmetric structure (MacFarlane and Seddon 2007) that is a result of weak 
intermolecular interactions of ions (bonhote, hidrofobic and welton hydrogen bonding).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.4.1 – Most common cation structures of nitrogen-
based ILs. 
Pyrrolidinium Imidazolium Piperidinium 
Pyridinium Ammonium 
Figure 1.2 – Most common families of cation in ILs 
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The first IL, ethylammonium nitrate, was synthetize by Paul Walden in 1914 in 
order to find a substitute to nitroglycerin. However, just in 1934 with an industrial 
application in preparation of cellulose solutions the first patent was registred by Charles 
Graenacher (Charles 1934) 
During the past decades the interest in ionic liquids had increased a lot, with 
applications in diverse areas of study. In Figure 1.4 are represented the number of 
publications of the last 20 years to clarify the “boom” of this area. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The first IL application was in electrolytes to batteries, and until now ILs are in 
the basis of importants electrochemical developments (Sato, Masuda, and Takagi 2004). 
ILs are included in reaction media for many organic transformations, separations and 
extractions, nanotechnology, biotechnology, and in engineering processes, among 
others (see Figure 1.5). Due to these diverse applications, ILs were used at an industrial 
scale by different companies ( e. g. BASF, Petronas, Eastman Chemical Company, 
Institut Français du Pétrole, Degussa, SASOL) to reactions like hydrogenations, 
polymerizations, alkylation as an illustrative example the numerous possible 
applications (Olivier-bourbigou and Magna 2002; Plechkova and Seddon 2008).  
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Figure 1.4 – Number of published article in the past 20 year. Values taken from IDI 
Web of Knowledge. 
Biomedical Applications Using Fluorinated Ionic Liquids 
General Introduction 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 11 
 
Applications 
of Ionic 
Liquids 
Engineering: 
-Coatings 
-Dispersing 
agents 
 
Electrochemistry: 
- Solar panels 
-Fuel cells 
Physical 
chemistry: 
-Refractive Index 
-Thermodynamics 
 
Biological 
uses: 
-Biocides 
-Drug delivery 
Analytics: 
- Matrices for 
mass 
spectrometry 
-Stationary phase 
for HPLC 
Solvents and 
catalysts: 
-Synthesis 
-Catalysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A more ambitious research area for ILs application is the pharmaceutical 
industry. Nowadays several groups try to take advantage of the unique properties of ILs 
to improve or develop new biomedical strategies (Ferraz et al. 2011; Florindo et al. 
2013; Stoimenovski et al. 2010). The Central Glass Company was the first company 
that produce pharmaceutical intermediates using ionic liquids, and also Eli Lilly adopt 
ILs for some industrial processes (Plechkova and Seddon 2008). 
This large campus of applications (represented in Figure 1.5) is the consequence of ILs 
properties that make that compounds very useful. Besides, ILs have low melting point, a 
negligible vapour pressure at room temperature, low flammability, high thermal and 
chemical stability, high ionic conductivity, high solvation ability for organic, inorganic 
and organometallic compounds, improved selectivity and ease recycling (Earle et al. 
2006; Rogers and Seddon 2003). 
Another advantage of ILs is the possibility to manage the final characteristics of 
the compounds, through the diverse possible combination of cations and anions. This 
tuneability allows the manipulation of some characteristics like hydrophobicity, 
thermophysical properties, bioavailability and toxicity (Ranke et al. 2007; Rogers and 
Seddon 2003) 
Figure 1.5 – Applications of ionic liquids (adapted fromPlechkova & Seddon, 2008) 
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1.4.1 Fluorinated Ionic Liquids (FILs) 
Despite the increasing amount of research in the ionic liquids field, there are still 
quite unexplored themes. That is the case of the fluorinated ionic liquids (FILs) family, 
here defined as ionic liquids with fluorine tags longer than four carbon atoms. These 
FILs are distinct from conventional fluorinated ionic liquids based on 
bis(trifluoromethylsulfonyl)imide, hexafluorophosphate or tetrafluoroborate anions 
which are ionic liquids studied extensively. It has been shown that fluorous phases 
present quite distinct behaviour from polar/non polar solvents (Tindale et al. 2007). The 
introduction of these unusual but potentially useful fluorous groups into the cation or 
anion pair can impart to ionic liquids attractive properties not observed in more 
conventional systems. The solvation in fully or partially fluorinated media is of full 
importance in areas where PFCs are used. This importance is related to the ability of 
fluorocarbon domains dissolving gases, to their low surface tension and outstanding 
chemical and biological inertness (Riess 2001). Fluorinated ionic liquids are of 
particular interest in relevant applications of perfluorocarbons such as imaging agents 
(Schutt et al. 2003; Stride and Edirisinghe 2009), fluorocarbon gels (Krafft and Riess 
1994), pulmonary delivery of drug and genes (Courrier, Vandamme, and Krafft 2004) 
and oxygen therapeutics (Riess 2005), where these compounds are used as gas carriers 
in liquid ventilation and intravenous formulations. 
The unique properties of fluorinated ionic liquids lead to high gas solubility and 
low forces required for expelling the gas molecules (regenerating the FIL) due to the 
repulsive tendency of fluorine atoms. The high solubility of gases, especially carbon 
dioxide in FILs has already been demonstrated (Almantariotis et al. 2010; Muldoon et 
al. 2007). A comparison between values for the CO2 solubility in a fluorinated ionic 
liquid (Muldoon et al. 2007)and in perfluoro-n-octane (Dias, Daridon, and Pa 2006) at 
similar conditions indicates that the new FILs have greater solubilisation capacities for 
CO2 than the traditional PFCs. On the other hand, FILs have also shown a good 
behaviour as surfactants, remarkably facilitating the formation and stabilization of 
dispersions of perfluorocarbons in a conventional IL (Merrigan et al. 2000). All the 
above mentioned properties of the neat FILs are essential to apply in the  (FIL+PFC)-
water emulsions as oxygen carriers where FILs could enhance the emulsion stability 
and increase the solubility of respiratory gas. 
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The FILs research with longer fluorinated chains are very scarce and are 
specially focused on synthesis and thermophysical characterization of compounds (Bara 
et al. 2009; Li et al. 2008; Linder and Sundermeyer 2009).  
In this work, the thermodynamic and thermophysical properties, toxicity and 
bioavailability of FILs were executed in order to evaluate the substitution partial or 
totally the PFCs in PFCs-emulsions used nowadays as oxygen therapeutics. In literature, 
there is a scarce of information about toxicity of these compounds (Pereiro et al. 2013) 
and no information about permeability in cell membranes was found.  
 
1.4.2 Ionic Liquids with Pharmaceutically active compounds 
 
The tuneable characteristic of ILs mentioned above display an important role for 
their application in different areas such as chemistry, biotechnology and pharmaceutical 
industry. In general, ionic liquids were grouped in three different families or 
generations. The first generation of ILs was focused only on their unique intrinsic 
physical and chemical properties (density, viscosity, conductivity, solubility and 
thermal and chemical stability). In the second generation of ILs, cations and anions 
properties could be designed to develop new materials kept the main properties of ILs. 
Recently, a new generation with pharmaceuticals applications in mind start to grow. 
This third generation use active pharmaceutical ingredients to produce ILs biological 
actives. The safety character of ILs in comparision with some high volatile and 
flammable organic solvents is also an advantage for these developments. Also the 
utilization of ILs as delivery platforms is nowadays in study. Besides, some APIs were 
designed as themselves ILs (Araújo et al. 2014b; Ferraz et al. 2011; Florindo et al. 
2013; Hough et al. 2007).With these approach physicochemical and biopharmaceutical 
characteristics of a drug could be managed in conjugation with different counter ions. 
The addition of ion pair could change the pharmacokinetics of a drug and reduce the 
undesired effects (Figure 1.6). Consequently, the final efficacy and security of the 
pharmaceutical product will be related to the salt structure (Araújo et al. 2014b; Ferraz 
et al. 2011).  
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Finally, this new generation of ILs represents a new opportunity to pharmaceutical 
industry once that there are an urgent need for innovative and efficient new drugs and 
therapies. In this work, the development of new cholinium based APIs were made in 
order to improve the biopharmaceutical characteristics of nalidixic acid, niflumic acid 
and pyrazinoic acid. The chemical structure of these APIs is represented in Figure 1.7. 
Nalidixic acid is part of a class of anti-microbial drugs called quinolones and is 
administrated in the treatment of urinary tract infections. However, the solubility in 
water of this API is less than 0.1 mg/ml and its bioavailability is limited. Niflumic acid 
is a nonsteroidal anti-inflammatory drug, part of fenamates family and is widely used in 
rheumatic disorders. Nevertheless, the poorly solubility in water is also a disadvantage 
for pharmaceutical industry. Pyrazinoic acid is the active metabolite of the anti-
tuberculosis drug pyrazinamide. The active form of this drug is not directly used due to 
poor absorption through the gastrointestinal tract (Araújo et al. 2014b; Takács-Novák et 
al. 2013). 
The aim of this work is evaluate the contribution of formulations with active 
pharmaceutical ingredients and ionic liquids. Properties such as high solubility were 
previously demonstrated, then another studies, like thermophysical behavior, 
cytotoxicity and partition properties were done. This new drug design is of full 
importance to pharmaceutical industry once that could avoid some disadvantages related 
to the classic formulations, including the formation of different solid forms, the straight 
liquid range of application, low solubility and low bioavailability of the original APIs. 
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Figure 1.7 - Chemical structure of active pharmaceutical 
ingredients in study 
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2.Fluorinated Ionic Liquids as Artificial Blood 
Substitutes 
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2.1.Thermophysical Characterization of 
Fluorinated Ionic Liquids
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2.1.1.Introduction 
Thermophysical and transport properties of ILs like density, viscosity, ionic 
conductivity and refractive index, are crucial for their application in industry. This 
information is a vital for process scale up, since it decisively affects technological operations 
like mixing, pumping, and stirring, and plays a crucial role in other properties like diffusion 
(Deive, Rivas, and Rodríguez 2011). Some physical properties and thermal characterisation 
are reported for fluorinated ionic liquids, but measurements of these properties have been 
performed for specific temperatures only (Almantariotis et al. 2010; Bara et al. 2009; Li et al. 
2008; Tindale, Mouland, and Ragogna 2010; Tsukada et al. 2006; Xue and Shreeve 2005). 
Therefore, there is a clear need for reliable systematic thermodynamic and thermophysical 
properties for these ionic liquids to point out their availability for use at the industrial 
processes level. 
The physicochemical properties of ILs in general and thus these FILs in particular can 
be fine-tuned through an adequate combination of the cation and the anion leading to the 
optimal physicochemical properties for each application. Nevertheless, this process would 
require wide collection of accurate physicochemical properties data for different families of 
FILs and the understanding of the relationships between each property and the ionic liquid 
intermolecular forces. This work provides a critical analysis of the thermodynamic and 
thermophysical properties of novel, non-volatile, recyclable fluorinated ionic liquids to 
establishment of guidelines for selecting the most suitable FILs for development of new and 
improved generation of artificial blood substitute. This characterization involves analysis of 
decomposition temperature, melting point, density, dynamic viscosity, refractive index, and 
ionic conductivity at atmospheric pressure in a large temperature interval. 
Melting and decomposition temperatures, are important  properties of ionic liquids, 
especially for their application as alternative solvents, because they determine the liquid range 
of the fluids and thus their range of application. And, the upper operating temperature of an 
ionic liquid is usually determined by the temperature at which it decomposes. Viscosity and 
density are the most relevant properties for any fluid phase; viscosity is a measure of the 
resistance of a fluid which is being deformed by either shear stress or tensile stress. The less 
viscous the fluid is, the greater its ease of movement (fluidity). All fluorinated ionic liquids  
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have a viscosity higher than water (Li et al. 2008; Tsukada et al. 2006) or PFCs (Grunert 
1994).  
 
Therefore, the viscosity will increase with the addition of FILs. However, FILs with 
high viscosity should not be selected because might present problems in promoting the 
dispersion of fluorinated compound in water. On the other hand, PFCs used in artificial blood 
substitute have a density around 1.5 (Rizzo et al. 2012) and FILs with similar densities are 
good candidates to increase the fluorinated domains of the emulsion. Additional transport 
properties, such as ionic conductivity and its relation with viscosity, known as ionicity, are 
also important for the characterization of pure fluorinated ionic liquids. 
Densities and related properties such as the molar free volumes can be related with the 
solubility of different species in mixtures containing ionic liquid, especially low molecular 
weight solutes that are gaseous at normal conditions (Tariq et al. 2009). Refractive index can 
also provide important insights on molar refractivity, which can be related to the solubility of 
low molecular weight solutes that are gaseous at normal conditions. These data will allow in 
the evaluation of these fluorinated ionic liquids to solubilise respiratory gases. The attained 
results will clearly impact applications using polyfluorinated compounds. 
 
 
2.1.2.Materials 
1-Ethyl-3-methylimidazolium trifluoromethanesulfonate, >99% mass fraction purity, 
1-methyl -3-octylimidazolium trifluoromethanesulfonate, >99% mass fraction purity (2-
hydroxyethyl)trimethylammonium bis(nonafluorobutylsulfonyl)imide, >97% mass fraction 
purity 1-ethyl–N–methylpyrrolidinium bis(nonafluorobutylsulfonyl)imide; 1-ethyl-3-
methylimidazolium perfluorooctanesulfonate; 1-dodecyl-3-methylimidazolium 
perfluorobutanesulfonate, >98% mass fraction purity; (2-hydroxyethyl)trimethylammonium 
perfluorobutanesulfonate >97% mass fraction purity, were acquired at Iolitec. The purity of 
the commercial ionic liquids was checked by 
1
H-NMR. 
1-Ethyl-3-methylimidazolium perfluoropentanoate, 1-methyl-3-octylimidazolium 
trifluoroethanoate, (2-hydroxyethyl)trimethylammonium perfluoropentanoate, (2-
hydroxyethyl)trimethylammonium perfluorohexanoate, (2-hydroxyethyl)trimethylammonium 
perfluorooctanoate and (2-hydroxyethyl)trimethylammonium perfluorooctanesulfonate were 
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synthesized in Molecular Thermodynamic Lab by ion exchange resin methods, as develop by 
Ohno et al (Fukumoto, Yoshizawa, and Ohno 2005).The purity of the final products was 
checked by 
1
H, 
13
C and 
19
F NMR and elemental analysis. 
Structures and acronyms of all fluorinated ionic liquids are shown in Table 2.1. All 
fluorinated ionic liquids were dried under vacuum (3.10
-2
 Torr) and vigorous stirring at 
323.15K for at least 2 days, immediately prior to their use. This step is crucial in order to 
reduce volatile impurities, as well, as water, which can influence the ionic liquids properties. 
The water content, determined by Karl Fisher titration, was less than 100 ppm for all the 
studied ionic liquids. No further purification was carried out. 
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Table 2.1 – Chemical structure and respective abbreviation of fluorinated ionic liquids in study 
FIL designation Chemical Structure 
1-Ethyl-3-methylimidazolium 
trifluoromethanesulfonate 
[EtMeIm][(CF3)SO3] 
 
1-Methyl -3-octylimidazolium 
trifluoromethanesulfonate 
[OcMeIm][(CF3)SO3] 
 
(2-Hydroxyethyl)trimethylammonium  
bis(nonafluorobutylsulfonyl)imide 
[NM3(EtOH)][NNf2] 
 
1-Ethyl–N–methylpyrrolidinium 
bis(nonafluorobutylsulfonyl)imide 
[EMpyr][NNf2] 
 
1-Dodecyl-3-methylimidazolium 
perfluorobutanesulfonate 
[DodMeIm][(PFBu)SO3] 
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FIL designation Chemical Structure 
2-Hydroxyethyl)trimethylammonium  
perfluorobutanesulfonate 
[NM3(EtOH)][(PFBu)SO3] 
 
1-Ethyl-3-methylimidazolium 
perfluorooctanesulfonate 
[EtMeIm][(PFOc)SO3] 
 
1-Ethyl-3methylimidazolium 
perfluoropentanoate 
[EtMeIm][(PFBu)CO2] 
 
1-Methyl -3-octylimidazolium 
trifluoroethanoate 
[OcMeIm][(CF3)CO2]  
(2-Hydroxyethyl)trimethylammonium 
perfluoropentanoate 
[NM3(EtOH)][(PFBu)CO2] 
 
(2-Hydroxyethyl)trimethylammonium 
perfluorohexanoate 
[NM3(EtOH)][(PFPe)CO2] 
 
(2-Hydroxyethyl)trimethylammonium 
perfluorooctanoate 
[NM3(EtOH)][(PFHep)CO2] 
 
(2-Hydroxyethyl)trimethylammonium 
perfluorooctanesulfonate 
[NM3(EtOH)][(PFOc)SO3] 
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2.1.3.Experimental Procedure 
 
Each fluorinated ionic liquid was taken from the respective schlenk flask with a 
syringe under a nitrogen flow to prevent humidity and was immediately placed in the 
apparatus. 
 
2.1.3.1.Thermal properties 
Thermogravimetric analyses (TGA) were carried out with a TA instrument Model 
TGA Q50, shown in Figure 2.1, where the thermal stabilities and decomposition temperatures 
of the fluorinated ionic liquids were measured. Nitrogen was used for the TGA measurements 
at a flow rate of 60 mL
.
min
-1
. Samples were placed inside of aluminium pans and heated to 
873 K at a rate of 1 K
.
min
-1
 until complete thermal degradation was achieved. Universal 
Analysis, version 4.4 software, was used to determine the onset (Tonset), the starting (Tstart) and 
the decomposition (Tdec) temperatures corresponding to the temperature at which the baseline 
slope changed during heating, the weight loss was 1 % and the weight loss was 50 %, 
respectively. A Differential Scanning Calorimeter (DSC) TA Instrument Model DSC Q200, 
shown in Figure 2.2, was used to measure the thermal properties of the fluorinated ionic 
liquids. The sample was continuously purged with 50 mL
.
min
-1 
of dinitrogen. About 5 to 10 
mg of fluorinated IL is crimped in an aluminum standard sample pan. Indium (melting point T 
= 429.76 K) was used as standard compound for the calibration of the DSC. 
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2.1.3.2.Viscosity and density measurements 
Measurements of viscosity and density were performed in the temperature range 
between 283.15 and 353.15 K at atmospheric pressure using an automated SVM 3000 Anton 
Paar rotational Stabinger viscometer-densimeter, Figure 2.3. The SVM 3000 uses Peltier 
elements for fast and efficient thermostability. The temperature uncertainty is ± 0.02 K. The 
uncertainty of the dynamic viscosity measurements is ± 0.5% and the absolute uncertainty of 
the density is ± 0.0005 g
.
cm
-3
. For each fluorinated ionic liquid triplicates were measured and 
the reported result is the average value with a maximum relative standard deviation (RSD) of 
0.51%. 
 
. 
 
 
 
 
 
Figure 2.1 - Thermogravimetric 
analyses model TGA Q50 (TGA). 
Figure 2.2 - Differential scanning 
calorimeter Model DSC Q200 (DSC) 
Figure 2.3 - SVM 3000 Anton Paar 
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 28 
 
 
2.1.3.3.Refractive index measurements 
The refractive index of the pure ionic liquids were determined using the automatic 
refractometer ABBEMAT 500 Anton Paar, Figure 2.4, with a resolution of ± 10
-6 
and the 
uncertainty in the experimental measurements of ± 4.10-5. The apparatus was calibrated by 
measuring the refractive index of Millipore quality water and tetrachloroethylene (provided 
by the supplier) before each series of measurements. For each fluorinated ionic liquid 
triplicates were measured. 
                    
 
 
2.1.3.4.Ionic conductivity measurements 
A CDM210 Radiometer Analytical conductimeter, Figure 2.5, was used to measure 
the ionic conductivities in a jacketed glass cell containing a magnetic stirrer. A water bath 
controlled to ± 0.01 K was used to thermostatize the cell. Cell temperature was measured by 
means of a platinum resistance thermometer coupled to a Keithly 199 System DMM/Scanner. 
The thermometer was calibrated against high accuracy mercury thermometers (0.01 K). For 
the electrical conductivity measurements, 1.5 mL of the sample was added to the thermostatic 
cell and vigorously stirred. The cell was closed with screw caps to ensure a secure seal and 
flushed with dry nitrogen to prevent humidity. Each measurement was performed as quickly 
as possible to minimize undesired effects, such as self-heating of the samples or ionization in 
the electrodes (Hamelin, Bose, and Thoen 1990) that might modify the measured conductivity 
values. This conductimeter uses an alter current of 12 V and a frequency of 2.93 kHz (4.00 
Figure 2.4 - Refractometer ABBEMAT 500 
Anton Paar. 
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mS range) in the range of conductivities measured. The use of high frequency alter current 
(greater than 600 Hz) and the fact that the electrodes are platinized avoids polarization  
phenomena at the surface of the cell electrodes  The conductimeter was previously calibrated 
at each temperature with certified 0.01 D and 0.1 D KCl standard solutions supplied by 
Radiometer Analytical. This technique was validated using the pure ionic liquids 1-ethyl-3-
methylimidazolium bis(trifluoromethylsulfonyl)imide and 1-hexyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide. The obtained results were compared with the published 
data using the impedance method showing maximum relative deviations of 2%. Every 
conductivity value was determined at least twice and the uncertainty of the measurements is 
estimated to be 1% in absolute value. 
 
 
 
 
 
 
 
 
 
 
 
2.1.4.Results and Discussion 
2.1.4.1.Thermal properties 
Melting and decomposition temperatures, are one of the most remarkable properties for ionic 
liquids, especially for their application as alternative solvents, because they determine the 
liquid range of the fluids and their range of application, which make them the most studied 
properties. The thermal properties (thermal stabilities, decomposition temperatures, melting 
points and glass transition temperatures) of the fluorinated ionic liquids studied in this work 
are summarized in Table 2.2 and Table 2.3.The melting points and decomposition 
Figure 2.5 - CDM210 Radiometer analytical 
conductimeter 
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temperatures for the fluorinated ionic liquids studied in this work as well as those others 
found in the literature (Cortes 2013; Pereiro et al. 2013)are illustrated in Figure 2.6.. 
 
  
 
Table 2.2 - Thermal properties of fluorinated ionic liquids: start temperature, Tstart, onset 
temperature, Tonset, decomposition temperature, Tdec. 
FIL Tstart
a
 / K Tonset
a
 / K Tdec
a
 / K 
[EtMeIm][(CF3)SO3] 577.95 609.56 633.26 
[OcMeIm][(CF3)SO3] 575.45 606.06 628.95 
[NM3(EtOH)][NNf2] 576.60 621.71 633.27 
[EMpyr][NNf2] 566.80 619.23 637.59 
[EtMeIm][(PFOc)SO3] 567.44 616.21 642.93 
[DodMeIm][(PFBu)SO3] 567.55 616.75 636.38 
[EtMeIm][(PFBu)CO2] 374.85 391.58 408.58 
[OcMeIm][(CF3)CO2] 415.99 423.26 438.74 
[NM3(EtOH)][(PFBu)SO3] 576.92 608.58 631.32 
[NM3(EtOH)][(PFBu)CO2] 405.66 414.15 420.53 
[NM3(EtOH)][(PFPen)CO2] 405.30 412.30 420.72 
[NM3(EtOH)] [(PFHep)CO2] 412.95 433.61 435.63 
[NM3(EtOH)] [(PFOc)SO3] 512.56 627.38 650.41 
a.Note that these values are from scanning TGA, and do not represent isothermal stability  
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Table 2.3.- Melting point, Tm, solid-solid transition temperature, Tsol-sol, and glass 
transition temperature, Tg for  fluorinated ionic liquids. 
FIL Tm / K Tsol-sol / K Tg / K 
[EtMeIm] [(CF3)SO3] 260.41 
246.52 
255.92 
 
[OcMeIm] [(CF3)SO3] 284.14 264.24  
[NM3(EtOH)][NNf2] 309.16 287.44 229.08 
[EMpyr][NNf2]  
261.41 
273.08 
 
[EtMeIm][(PFOc)SO3]  
323.91 
368.33 
 
[DodMeIm][(PFBu)SO3] 310.66 
310.66 
297.47 
 
[NM3(EtOH)][(PFBu)SO3]  
236.46 
258.68 
337.84 
376.53 
 
[EtMeIm][(PFBu)CO2] 277.63 
236.74 
249.88 
254.34 
 
[OcMeIm][(CF3)CO2] 279.45  189.12 
[NM3(EtOH)][(PFBu)CO2]  
273.93 
289.55 
 
[NM3(EtOH)][(PFPe)CO2]  314.23  
[NM3(EtOH)][(PFHep)CO2]  339.67  
[NM3(EtOH)] [(PFOc)SO3]  
221.96 
364.46 
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Figure 2.6 - Melting points and decomposition temperatures of the fluorinated ionic 
liquids in study and the available s in literature (Cortes 2013; Pereiro et al. 2013) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to explore the application of fluorinated ionic liquids for artificial gas carriers 
and blood substitutes the most relevant temperature is 310.15 K since is accepted as the 
average temperature of human body. 
The analysis of experimental data studied in this work and those data available in 
literature allows us to draw some conclusions. 
Almost fluorinated ionic liquids shows one or more solid-solid transition, reported in 
Table 2.3, that behaviour is connected with the presence of different crystalline structures 
which are formed during cooling ramps. 
Once that [EMpyr][NNf2], [EtMeIm][(PFOc)SO3], [NM3(EtOH)][(PFBu)SO3], 
[NM3(EtOH)][(PFBu)CO2, [NM3(EtOH)][(PFPe)CO2], [NM3(EtOH)][(PFHep)CO2] and 
[NM3(EtOH)] [(PFOc)SO3] begin the process of decomposition before melting it is not 
possible to determine that last temperature. 
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In the presence of cholinium cation, [NM3(EtOH)], the decomposition temperature are 
lower for carboxylate than for sulfonate anion. However, an increasing of the fluorinated 
chain length in carboxylate anions is attached with an increase in decomposition temperature, 
Figure 2.6. 
A comparison between two families of anions, sulfonate and carboxylate, was carried 
out. With this aim in mind, two different imidazolium cations, [EtMeIm]
+
 and [OcMeIm]
+
, 
were considered. In terms of melting temperature ionic liquids based on carboxylate anion 
have a lower melting point:  
 [EtMeIm]+ - [(PFBu)SO3]¯ > [(PFBu)CO2]¯ 
 [OcMeIm]+ - [(PFBu)SO3]¯ > [(CF3)CO2]¯ 
For decomposition temperatures, ionic liquids based on sulfonate anion are more 
stable because have higher decomposition temperatures. 
 [EtMeIm]+ - [(PFBu)SO3]¯ > [(PFBu)CO2]¯ 
 [OcMeIm]+ - [(PFBu)SO3]¯ > [(CF3)CO2]¯ 
The effect of increasing the hydrogenated alkyl chain length of the cation in thermal 
properties can be studied in imidazoliums and pyrrolidiniums ionic liquids, with the anions 
triflate, [(CF3)SO3]¯and perfluorobutanesulfonate, [(PFBu)SO3]¯.  
For [(CF3)SO3]¯ and [(PFBu)SO3]¯, the melting temperature increases with the 
increment of hidrogenated alkyl chain: 
 [(CF3)SO3]¯ - [EtMeIm]+ < [OcMeIm]+ 
 [(PFBu)SO3]¯ - [EtMeIm]
+
 < [HexMeIm]
+
 < [OcMeIm]
+
 < [DoMeIm]
+
 
The decomposition temperature of these compounds decreases with the increment of 
the hydrogenated alkyl chain. 
 [(CF3)SO3]¯ - [EtMeIm]
+
 > [OcMeIm]
+
 
[(PFBu)SO3]¯ - [EtMeIm]
+
 > [HexMeIm]
+
 > [OcMeIm]
+
 > [DoMeIm]
+
 
The effect of the increment on the fluorinated chain using cholinium, and 
imidazolium ionic liquids can be also evaluated. In the case of cholinium ionic liquids 
based on carboxilate anion, melting point cannot be measured in this range of 
temperatures because these compounds decompose before reaching  
the melting point, like mencioned above. On the other hand, the decomposition 
temperature increases slightly with the increment of fluorinated chain: 
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 Cholinium - [(PFBu)CO2]¯ > [(PFPe)CO2]¯ > [(PFHep)CO2]¯ 
For imidazolium ionic liquids based on sulfonate anion, the melting temperature 
increases in ionic liquids with higher number of fluor atoms in alkyl chain:  
 Imidazolium - [(CF3)SO3]¯ < [(PFBu)SO3]¯  
In the case of ionic liquids [EtMeIm][(PFOc)SO3], it was not possible determine the 
melting temperature because this FIL decomposes before reaching the melting point. 
Taking into account the effect of cation in decomposition temperature for 
perfluorooctanesulfonate anion, [(PFOc)SO3]¯, decreases according to the following order:  
 Cholinium > Imidazolium > Ammonium 
From the exclusive analysis of thermal properties results and taking into account the 
data available in literature, the better ionic liquids for biomedical applications are 
[EtMeIm][(CF3)CO2] and [EtMepy][(PFBu)SO3], with lower melting temperatures and more 
stability in a wide temperature range (high decomposition temperatures).Melting point of 
ionic liquids based on cholinium cation cannot be determined because they decompose before 
reaching the melting point. Furthermore, [BuMepyr][NNf2] and [NBu4][(PFBu)SO3] ionic 
liquids are not good candidates for biomedical applications, because they stay in solid state at 
temperatures higher than human body. To conclude, no specific overall rule can be extracted 
for melting and decomposition temperatures. However, if the fluorinated ionic liquids are 
analysed as separate families, some consistent effects are observed. 
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2.1.4.2.Thermophysical and thermodynamic properties 
The experimental density, dynamic viscosity, refractive index and ionic conductivities 
of fluorinated ionic liquids as a function of temperature are listed in Table 2.4. 
 
 
Table 2.4 – Density, ρ, dynamic viscosity, η, refractive index, nD, and ionic conductivity, k, 
of the pure fluorinated ionic liquids as a function of temperature. 
T / K ρ /g·cm-3 η /mPa·s nD k/mS·cm
-1
 
[EtMeIm][(CF3)SO3] 
293.15 1.3884 51.40 1.43451 0.767 
298.15 1.3842 42.60 1.43294 0.902 
303.15 1.3800 35.72 1.43151 1.07 
308.15 1.3758 30.29 1.43012 1.23 
313.15 1.3717 25.86 1.42870 1.42 
318.15 1.3677 22.40 1.42730 1.61 
323.15 1.3636 19.52 1.42593 1.82 
328.15 1.3595 17.13 1.42459  
333.15 1.3552 15.10 1.42325  
      338.15 1.3512 13.45 
1.42132 
 
343.15 1.3471 12.04 1.42007  
348.15 1.3429 10.82 1.41878  
353.15 1.3386 9.75 1.41751  
[OcMeIm][(CF3)SO3] 
293.15 
1.1911 305.1 1.44460 
0.436 
298.15 
1.1873 226.1 1.44319 
0.576 
303.15 
1.1836 170.6 1.44178 
0.743 
308.15 
1.1799 131.1 1.44037 
0.937 
313.15 
1.1763 102.8 1.43890 
1.18 
318.15 
1.1726 81.42 1.43735 
1.46 
323.15 
1.1690 65.59 1.43582 
1.78 
328.15 
1.1654 53.52 1.43425 
 
      333.15 
1.1618 44.38 1.43273 
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T / K ρ /g·cm-3 η /mPa·s nD k/mS·cm-1 
[OcMeIm][(CF3)SO3] 
338.15 1.1583 36.94 1.43128  
343.15 1.1548 31.16 1.42981  
348.15 1.1512 26.53 1.42853  
353.15 1.1476 22.90 1.42714  
[NM3(EtOH)][NNf2] 
303.15 1908 1908   
308.15 1324 1324 1.37365 0.096 
310.15    0.109 
313.15 937.4 937.4 1.37234 0.126 
315.15    0.151 
318.15 677.7 677.7 1.37103 0.171 
320.15    0.196 
323.15 500.5 500.5 1.36975 0.226 
328.15 1.6559 375.7 1.36844  
333.15 1.6501 287.1 1.36714  
338.15 1.6444 222.3 1.36590  
343.15 1.6388 174.7 1.36463  
348.15 1.6311 139.1 1.36340  
353.15 1.6272 112.0 1.36211  
[DodMeIm][(PFBu)S 
308.15 1.2495 386.1  0.155 
310.15    0.176 
313.15 1.2450 277.9 1.41616 0.206 
315.15    0.239 
318.15 1.2406 205.1 1.41467 0.265 
320.15    0.292 
323.15 1.2364 155.0 1.41317 0.336 
328.15 1.2322 155.0 1.41317  
333.15 1.2279 119.6 1.41171  
338.15 1.2237 94.10 1.41026  
343.15 1.2195 74.78 1.40880  
348.15 1.2153 60.48 1.40734  
353.15 1.2110 49.54 1.40590  
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T / K ρ /g•cm-3 η /mPa•s nD k/mS•cm-1 
[EtMeIm][(PFBu)CO2] 
283.15 1.4783 262.8 1.40161 0.825 
288.15 1.4976 190.1 1.40019 1.11 
293.15 1.4921 141.3 1.39877 1.46 
298.15 1.4868 107.5 1.39736 1.87 
303.15 1.4815 83.32 1.39595 2.35 
308.15 1.4762 65.87 1.39454 2.88 
313.15 1.4710 52.80 1.39315 3.50 
318.15 1.4659 43.09 1.39173 4.19 
323.15 1.4607 35.63 1.39036 4.96 
328.15 1.4556 29.80 1.38899  
333.15 1.4505 25.27 1.38760  
338.15 1.4454 21.51 1.38626  
343.15 1.4403 18.51 1.38493  
283.15 1.4783 262.8 1.40161  
[OtMeIm][(CF3)CO2] 
283.15 
1.1260 421.2 1.45306 
0.272 
288.15 
1.1223 297.2 1.45156 
0.385 
293.15 
1.1186 214.3 1.45010 
0.525 
298.15 
1.1149 159.6 1.44863 
0.696 
303.15 
1.1113 120.9 1.44716 
0.901 
308.15 
1.1076 93.43 1.44572 
1.14 
313.15 
1.1040 73.72 1.44425 
1.43 
318.15 
1.1005 58.71 1.44279 
1.76 
323.15 
1.0969 47.60 1.44132 
2.14 
283.15 
1.1260 421.2 1.45306 
0.272 
328.15 
1.0934 39.11 1.43993 
 
333.15 
1.0899 32.64 1.43850 
 
338.15 
1.0864 27.37 1.43709 
 
343.15 
1.0829 23.24 1.43573 
 
348.15 
1.0794 19.91 1.43432 
 
353.15 
1.0760 17.29 1.43295 
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The densities, fluidities (1 / dynamic viscosity) and ionic conductivities of the 
fluorinated ionic liquids measured in this work, as some of available in literature(Cortes 2013; 
Pereiro et al. 2013)are presented in Figure 2.7, Figure 2.8 and Figure 2.9, respectively 
Density and fluidity (inverse of dynamic viscosity) are relevant characteristics when it 
comes to biomedical applications, such as blood substitutes, because this properties are 
crucial for the transport and delivery of respiratory gases (oxygen and carbon dioxide) (Riess 
and Krafft 1998). The density of blood (1.05 g·cm
-3
)(Riess 2001)(Owens et al. 2006)  and of 
PFCs (1.5 g·cm
-3
) are considered as reference values for the analysis of this physical property. 
The best candidates will be  the ionic liquids with a density value closer to the density of 
PFCs used nowadays in oxygen therapeutic emulsions (1.5g g·cm
-3
)(Fraker, Mendez, and 
Stabler 2011) because this work explores the possibility of replacement (either partially or 
totally) of PFCs with  
 
 
Figure 2.7 - Density and fitted curves as a function of temperature for the 
fluorinated ionic liquids. 
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selected fluorinated ionic liquids in oxygen therapeutic emulsions. It is thought that FILs are 
more able to solubilize respiratory gases than PFC emulsions (increasing fluorinated domain 
in these emulsions) and they can enhance the stability of PFCs because they can act as 
surfactants. 
Firstly, a comparison between the ionic liquids with carboxilate and sulfonate anions 
shows that density is lower for ionic liquids based on carboxylate anion: 
 [EtMeIm]+ - [(PFBu)SO3]¯ > [(PFBu)CO2]¯ 
 [OcMeIm]+ - [(CF3)SO3]¯ > [(CF3)CO2]¯ 
In this study, the effect of increasing the hydrogenated alkyl chain length in the 
imidazolium cation can be evaluated using  two different anions, [(CF3)SO3]¯ and 
[(PFBu)SO3]¯. This comparison shows that in the case of  [(CF3)SO3]¯ anion, the density 
decreases with the increasing of hydrogenated alkyl chain and the same behaviour can be 
observed  with the [(PFBu)SO3]¯ anion: 
 [(CF3)SO3]¯ - [(EtMeIm)]
+
 < [(OcMeIm)]
+
  
 [(PFBu)SO3]¯ - [(EtMeIm)]
+
 < [(HexMeIm)]
+
 < [(OcMeIm)]
+
 < [(DoMeIm)]
+
 
Finally, the increment of fluorinated alkyl chain can be examined for the same cation, 
imidazolium where the increment of the number of fluoro atoms in the alkyl chain increases 
the density of these ionic liquids. 
 [(EtMeIm)]+ – [(CF3)SO3]¯ < [(PFBu)SO3]¯ 
In conclusion, for the application studied in this work,  ionic liquids with the density 
closer to PFCs  are [EtMeIm][(PFBu)SO3], [EtMeIm][(PFBu)CO2] and 
[EtMepy][(PFBu)SO3]. 
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The fluidity of a pure ionic liquid is also an important characteristic for biomedical 
application and this property is very sensitive to temperature The effect of the increment of 
the hydrogenated alkyl chain length in FILs based on imidazolium cations can be evaluated 
with [(CF3) SO3]¯ and [(PFBu)SO3]¯ anions. Fluidity of these ionic liquids decreases with the 
increment of hydrogenated alkyl chain length: 
 [(CF3) SO3]¯ - [(EtMeIm)]
+
 >[(OcMeIm)]
+
  
 [(PFBu)SO3]¯ - [(EtMeIm)]
+
 > [(HexMeIm)]
+
 > [(OcMeIm)]
+
 > [(DoMeIm)]
+
 
The increment of fluorinated alkyl chain can be also evaluate taking into account ionic 
liquids based on imidazolium cation where the fluidity decreases with the increment of the 
fluorinated alkyl chain length:  
 [(EtMeIm)]+ - [(CF3)SO3]¯ >[(PFBu)SO3]¯ 
Moreover, a comparison between the ionic liquids based on carboxilate and sulfonate 
anions shows that carboxilate anion improve the fluidity of these FILs: 
 [EtMeIm]+ - [(PFBu)SO3]¯ < [(PFBu)CO2]¯ 
 [OcMeIm]+ - [(CF3)SO3]¯ < [(CF3)CO2]¯ 
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The best ionic liquids for the application studied in this work are the less viscous such 
as FILs based on [(CF3)CO2]¯, [EtMeIm][(PFBu)SO3] and [EtMeIm][(PFBu)CO2]. 
The temperature dependence of the density and the refractive index was studied by applying 
the following expression: 
 (2.1) 
 (2.2) 
where T is the absolute temperature and , and are adjustable parameters. The 
correlation parameters are given in Table 2.5 together with the standard deviations 
(S.D.). These deviations were calculated by applying the following expression: 
 
 
(2.3) 
where property values and the number of experimental and adjustable data are represented by 
z and , respectively. 
Arrenius fitting for fluidity, , and of the ionic conductivity, , was well carried out 
using Vogel-Fulcher-Tammann (VFT) equation: 
 
 
(2.4) 
 
where  designates the thermophysical property fluidity, , or ionic conductivity, , and , 
which corresponds to  or . B and T0 are constants. The fitting parameters of the fluidity 
and ionic conductivity are also summarized in Table 2.5. This equation is used to show 
temperature dependence of ionic conductivity and viscosity. 
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Table 2.5 - Fitting parameters for the density (equation 2.1), refractive index (equation 
2.2), fluidity (equation 2.4) and ionic conductivity (equation 2.4) as a function of 
temperature for the studied fluorinated ionic liquids. Standard deviations (S.D.) 
(equation 2.3) are also shown. 
[EtMeIm][(CF3)SO3] 
 /g
.
cm
-3
 A0 = 0.5079 A1 = - 6.125 · 10
-4
  S.D. = 1.5 
.
 10
-4
 
nD A0 = 1.5128 A1 = - 2.680 · 10
-4
  S.D. = 9.0 
.
 10
-4
 
 / mPa
-1.
s
-1
 0 = 6.52
 
B = 872.90 T0 = 143.01 S.D. = 8.2 
.
 10
-5
 
k/ mS
.
cm
-1
 k0 = 1289.68
 
B = 1700.67 T0 = 63.72 S.D. = 9.7 
.
 10
-3
 
[OtMeIm][(CF3)SO3] 
 /g
.
cm
-3
 A0 = 0.3590 A1 = - 6.280 · 10
-4
  S.D. = 2.3 
.
 10
-4
 
nD A0 = 1.5262 A1 = - 2.787 · 10
-4
  S.D. = 9.4 
.
 10
-4
 
 / mPa
-1.
s
-1
 0 = 3.70
 
B = 705.42 T0 = 194.51 S.D. = 2.2 
.
 10
-4 
k/ mS
.
cm
-1
 k0 = 1494.13
 
B = 1170.71 T0 = 149.30 S.D. = 2.3 
.
 10
-3
 
[NM3(EtOH)][NNf2] 
 /g
.
cm
-3
 A0 = 0.7339 
A1 = -6.994 · 10
-4
  S.D. = 5.7 
.
 10
-5
 
nD A0 = 1.5223 
A1 = -2.656 · 10
-4
  S.D. = 1.0 
.
 10
-3
 
 / mPa
-1.
s
-1
 0 = 1.65 B = 707.68 T0 = 217.90 S.D. = 8.0 
.
 10
-5
 
k/ mS
.
cm
-1
 k0 = 1861.53 B = 1547.55 T0 = 151.42 S.D. = 2.8 
.
 10
-3
 
[DoMeIm][(PFBu)SO3] 
 /g
.
cm
-3
 A0 = 0.3827 
A1 = -5.169 · 10
-4
  S.D. = 8.0 
.
 10
-3
 
nD A0 = 1.4539 
A1 = -2.584 · 10
-4
  S.D. = 1.0 
.
 10
-3
 
 / mPa
-1.
s
-1
 0 = 3.45 B = 707.00 T0 = 210.66 S.D. = 9.1 
.
 10
-5
 
k/ mS
.
cm
-1
 k0 = 1914.49 B = 1617.66 T0 = 136.00 S.D. = 4.0 
.
 10
-3
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[EtMeIm][(PFBu)CO2] 
 /g
.
cm
-3
 A0 = 0.5990 
A1 = - 6.819 · 10
-4
  S.D. = 7.5 
.
 10
-4
 
nD A0 = 0.3942 
A1 = - 2. 000 · 10
-4
  S.D. = 5.1 
.
 10
-5
 
 / mPa
-1.
s
-1
 0 = 8.33 B = 875.63 T0 = 169.36 S.D. = 5.6 
.
 10
-5
 
k/ mS
.
cm
-1
 k0 = 1289.68 B = 1700.67 T0 = 63.72 S.D. = 1.7 
.
 10
-2
 
[OcMeIm][(CF3)CO2] 
 /g
.
cm
-3
 A0 = 0.3045 
A1 = - 6.558. 10
-4
  S.D. = 1.9 
.
 10
-4
 
nD A0 = 0.4320 
A1 = - 2. 057 · 10
-4
  S.D. = 1.5 
.
 10
-4
 
 / mPa
-1.
s
-1
 0 = 8.19 B = 876.26 T0 = 176.21 S.D. = 8.4 
.
 10
-5
 
k/ mS
.
cm
-1
 k0 = 1511.97 B = 1113.32 T0 = 153.72 S.D. = 6.2 
.
 10
-3
 
 
2.1.4.3.Free Volume 
The refractive index can be used as a measure of the electric polarizability of a 
molecule and can provide useful information when studying the forces between molecules or 
their behaviour in solution(Tariq et al. 2009). Polarizability is the measure of the change in a 
molecule's electron distribution in response to an applied electric field, which can also be 
induced by electric interactions with solvents or ionic solvents. Polarizabilities determine the 
dynamical response of a bound system to external fields, and provide insight into a molecule's 
internal structure (Zhou 2003). The Lorenz-Lorentz equation relates the electronic 
polarizability, , with the refractive index, , and can also be expressed in terms of the 
molar refraction, or molar polarizability (Moldover 2007), Rm, using the expression: 
 
 
(2.5) 
where the  is the Avogadro’s constant and  the molar volume. 
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 44 
 
The relation between the polarizability and the refractive index shown above can 
provide important information about the behaviour of a liquid as a solvent media and 
constitutes a measure of the importance of the dispersion forces to the cohesion of the liquid. 
Therefore, solvents with a large index of refraction, and consequently large polarizability, 
should be capable of enjoying particularly strong dispersion forces(Reichardt and Welton 
2011), being also good solvents for species possessing high polarizabilities. Molar refractions 
can be considered as a measure of the hard-core molecular volumes because the electronic 
polarizability can be related to a spherical molecular radius(Tariq et al. 2009), , as follows: 
 
 (2.6) 
and the equation 4 can be expressed in the following form: 
 
 
(2.7) 
 
where  is the free volume defined as: 
 
 (2.8) 
 
which means that  is directly proportional to the occupied part of the molar volume, 
Rm being then considered as the hard-core molecular volume (Deetlefs, Seddon, and Shara 
2006).  
The molar free volumes can be related to the solubility of low molecular weight 
solutes that are gaseous at normal conditions (Tariq et al. 2009) The values for the calculated 
molar refractions (from equation 2.5) and free volumes (from equation 2.8), from Lorentz-
Lorenz equation, of all the studied fluorinated ionic liquids were calculated and are listed in 
Table 2.6 together  with the values for molar volume, that is illustrated in Figure 2.9 , these 
results were also comparable with those available in literature (Cortes 2013; Pereiro et al. 
2013).
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotecnhology, FFCU Page 45 
 
  
Table 2.6 - Values of calculated molar volume, Vm, molar refraction, Rm, and free 
volume, fm, as a function of temperature for the studied fluorinated ionic liquids. 
T/K /cm
3
·mol
-1
 /cm
3
·mol
-1
 /cm
3
·mol
-1
 
[EtMeIm][(CF3)SO3] 
293.15 187.42 48.86 138.57 
298.15 187.99 48.85 139.14 
303.15 188.56 48.86 139.70 
308.15 189.14 48.87 140.27 
313.15 189.70 48.88 140.83 
318.15 190.26 48.88 141.38 
323.15 190.83 48.89 141.95 
328.15 191.41 48.90 142.50 
333.15 192.01 48.93 143.09 
338.15 192.58 48.87 143.72 
343.15 193.17 48.89 144.28 
348.15 193.77 48.91 144.86 
353.15 194.40 48.94 145.46 
[OctMeIm][(CF3)SO3] 
293.15 289.13 76.89 212.24 
298.15 290.05 76.93 213.13 
303.15 290.96 76.96 214.00 
308.15 291.87 76.98 214.89 
313.15 292.76 76.99 215.77 
318.15 293.69 77.00 216.68 
323.15 294.59 77.00 217.60 
328.15 295.50 77.00 218.50 
333.15 296.42 76.99 219.43 
338.15 297.31 77.01 220.31 
343.15 298.22 77.01 221.21 
348.15 299.15 77.04 222.11 
353.15 300.09 77.06 223.02 
[NM3(EtOH)][NNf2] 
308.15 477.71 109.02 368.69 
313.15 478.20 108.76  
318.15 478.65 108.53 370.12 
323.15 479.07 108.31 370.76 
328.15 479.52 108.07 371.46 
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T/K Vm/cm
3•mol-1 R_m/cm3•mol-1 fm/cm
3•mol-1 
[NM3(EtOH)][NNf2] 
333.15 480.02 107.81 372.20 
338.15 480.44 107.59 372.85 
343.15 480.90 107.35 373.55 
348.15 481.32 107.13 374.19 
353.15 481.78 106.88 374.89 
[DoMeIm][(PFBu)SO3] 
303.15 440.56 116.20 324.36 
308.15 442.16 116.28  
313.15 443.72 116.34 327.38 
318.15 445.23 116.37 328.87 
323.15 446.75 116.41  
328.15 448.31 116.44 331.87 
333.15 449.85 116.51  
338.15 451.40 116.56 334.84 
343.15 452.96 116.65 336.31 
348.15 454.57 116.73 337.83 
353.15 440.56 116.20 324.36 
[EtMeIm][(PFBu)CO2] 
283.15 249.65 60.74 188.91 
288.15    
293.15 250.76 60.62 190.13 
298.15 251.66 60.65 191.01 
303.15 252.66 60.68  
308.15 253.46 60.70  
313.15 254.35 60.73 193.63 
318.15 255.25 60.75 194.51 
323.15 256.15 60.77 195.38 
328.15 257.05 60.79 196.26 
333.15 257.95 60.81 197.14 
338.15 258.86 60.84 198.02 
343.15 259.77 60.87 198.91 
348.15 260.69 60.89 199.80 
353.15 261.62 60.92 200.70 
[OcMeIm][(CF3)CO2] 
283.15 273.83 74.02 199.81 
288.15 274.73 74.05  
293.15 275.64 74.09 201.55 
298.15 276.54 74.12  
303.15 276.54 74.12 202.42 
308.15 277.45 74.15 203.30 
313.15 279.27 74.22 205.05 
318.15 280.18 74.25 205.93 
323.15 281.08 74.28 206.81 
328.15 257.05 60.79 196.26 
333.15 257.95 60.81 197.14 
338.15 283.81 74.37 209.44 
343.15 284.72 74.40 210.32 
348.15 285.64 74.43 211.20 
353.15 286.55 74.47 212.09 
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotecnhology, FFCU Page 47 
 
Figure 2.9- Molar free volume as a function of temperature (T) for the fluorinated ionic 
liquids. 
 
 
 
 
 
 
Taking into account the nature of FIL’s, molar free volume is one of the most 
important properties for their use in gas separation and delivery.  
A comparison between ionic liquids with carboxilate and sulfonate anions shows that 
the sulfonate anion improves the molar free volume in these FILs: 
 [EtMeIm]+ - [(PFBu)SO3]¯ > [(PFBu)CO2]¯[OcMeIm]
+
 - [(CF3)SO3]¯ > [(CF3)CO2]¯ 
From the analysis of experimental results obtained in this work for two different 
anions, [(CF3)CO2]¯ and [(PFBu)SO3]¯, it can conclude that molar free volume increase with 
the increment of hydrogenated alkyl chain in imidazolium cation:. 
 [(CF3)CO2]¯ - [EtMeIm]
+
 < [OcMeIm]
+
 
 [(PFBu)SO3]¯ - [EtMeIm]
+
 < [HexMeIm]
+
 < [OcMeIm]
+
 < [DoMeIm]
+
 
The increment of fluorinated alkyl chain, in FILs with imidazolium cation, also 
increases the molar free volume of these ionic liquids: 
  [(EtMeIm)]+ - [(CF3)SO3]¯ < [(PFBu)SO3]¯ 
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Relatively to the family type of cation and take in to account the [(PFBu)SO3]¯anion, 
the molar free volume trend is to increase accordingly to that order: 
Pyridinium < Imidazolium < Ammonium 
To conclude, taking into account the free molar volume analysed in this discussion, 
[NM3(EtOH) ][ NNf2] , [NBu4][(PFBu)SO3] and [DoMeIm][(PFBu)SO3], are the most 
appropriate ionic liquids for this application that involve diffusion of gases. The very strong 
C−F bonds existent in FILs cause an increase in rigidity of the molecular structure and a 
decrease in polarity. This fact justifies the increment of molar free volumes and molar 
volumes of FILs with long fluorinated chains (Pereiro et al. 2013). The [ NNf2]
-
 anion of 
[NM3(EtOH) ][ NNf2] has a higher number of fluors than the others, so like it was expected 
that ionic liquid due to his high molar volume  is very good for gas separation processes like 
diffusion of O2 and CO2. [NBu4][(PFBu)SO3] and [DoMeIm][(PFBu)SO3] have also high 
molar volumes, the first case is realated to the structure of the cation and the second case is 
related to the hydrogenated chain lengt, these features make an increase in the molar free 
volume. 
 
2.1.4.4.Walden Plot 
The Walden plot is a convenient and versatile tool to measure the ionicity of ionic 
liquids  since establish a relationship between the molar conductivity and the viscosity or 
fluidity of a fluid. A way to determine the efficiency of an ionic liquid as an electrolyte, 
solvent, or reaction medium, has been proposed Walden rule. The Walden rule (Walden 1906) 
gives information on relationship between ion mobility and viscosity. In the case of an ideal 
ionic liquid conductor, conductivity is only influenced by the viscosity (Papaiconomou et al. 
2012) in the form: 
 
 
(2.9) 
where the molar conductivity is expressed in S cm
2
 mol
-1
 and the viscosity ( ) is expressed in 
poise, and  is a constant. “The fractional” Walden model added an exponent α (Harris 2010). 
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(2.10) 
 
For ionic liquids it has been shown that the molar conductivity can be calculated 
by(Papaiconomou et al. 2012): 
 
 
(2.11) 
 
with the  conductivity in S cm
-1
, the  the density in g cm
-3
 and  the molecular weight in 
g mol
-1
. The eq. (2.11) can be expressed by: 
 
 
(2.12) 
 
The Walden-plot is usually represented by the  as a function 
of  (Harris 2010) and is a good and versatile tool to measure ionicity of inorganic 
salts solutions and ionic solvents. The straight line of Figure 2.10 and Figure 2.11fixes the 
position of the “ideal” electrolyte, where the system is known to be fully dissociated and to 
have ions of equal mobility. Usually, the behaviour of diluted aqueous potassium chloride 
solutions are taken as the behaviour of an ideal electrolyte (Miran et al. 2012). For the unit 
chosen, the ideal line runs from corner to corner of a square diagram (Xu, Cooper, and Angell 
2003).Figure 2.10 shows the classification proposed by Angell and co-workers (Xu et al. 
2003) for “good” and “poor” ionic liquids. 
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Figure 2.10 - Classification proposed by Angell and co-workers  for “good” and “poor” 
ionic liquids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ionic conductivity and its relation with viscosity, known as ionicity, provide useful 
information about transport properties, mobility and the possible formation of aggregates in 
ionic liquids. The formation of aggregates could decrease the mobility of these FILs and 
increase its viscosity, obtaining a ionicity behaviour away from ideal electrolyte. Clearly, the 
Figure 2.11 - Walden plot for the fluorinated ionic liquids. 
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increment of ionicity improves the physical properties of FILs that could be used in artificial 
blood substitutes. Experimental information on ionicity of fluorinated ionic liquids is 
extremely scarce in literature review and experimental data are available for only six FILs 
(Pereiro et al. 2013). The data obtained for the fluorinated ionic liquids studied in this work 
and the presents in literature (Cortes 2013; Pereiro et al. 2013) are represented in Figure 2.10 
and Figure 2.11 together with the classification proposed by Angell and co-workers (Xu et al. 
2003). For each fluorinated ionic liquid, the Walden plot has a linear behaviour with the 
temperature. 
In the walden plot, a comparison between our fluorinate ionic liquids with the ideal 
electrolyte is carried out. 
Fluorinated ionic liquids with a sulfonate group shows high iconicity than with a 
carboxylate group, for the same imidazolium cation, [(EtMeIm)]
+
. 
 [(EtMeIm)]+: [(PFBu)SO3]¯> [(PFBu)CO2]¯ 
By the analysis of this data it can be concluded that the increment of hydrogenated 
alkyl chain in imidazolium cation is related to a decrease of ionicity in [(PFBu)SO3]¯ anion. 
 [(PFBu)SO3]¯: - [(EtMeIm)]
+
 > [(HexMeIm)]
+
 > [(OcMeIm)]
+
 > [(DoMeIm)]
+
 
A decreasing in ionicity is also related to the increment of fluorinated length chain, for 
imidazolium cations. 
 [(EtMeIm)]+: [(CF3)SO3]¯> [(PFBu)SO3]¯ 
 [(OcMeIm)]+: [(CF3)SO3]¯> [(PFBu)SO3]¯ 
The difference in ionicity for two different cation families, imidazolium and 
pyridinium could be evaluated with [(PFBu)SO3] anion. In these comparison, the higher 
iconicity in the presence of imidazolium cation is verified. 
 Imidazolium > Pyridinium 
 
For all above mentioned reason, and by the direct analysis of Figure 2.11 the best 
candidates to use in oxygen therapeutic emulsions are [(EtMeIm)][(CF3)SO3], and 
[(EtMeIm)][(PFBu)SO3]] which present a behaviour closest to ideal electrolyte. 
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2.1.5.Conclusions 
The final goal of this chapter is to measure the thermodynamic and thermophysical 
properties of 13 FILs in order to expand knowledge of FILs and understand its behaviour as 
pure fluid so that they can be used in oxygen therapeutics based on PFCs-emulsions. Here 
some comparisons with the values available in literature were also presented to establish of 
guidelines for selecting the most suitable FILs for this application. 
The viscosity of PFC-based emulsions should increase when is added a good 
surfactant with aim to enhance the stability of emulsions. All the fluorinated ionic liquids 
have higher viscosity than the PFCs and can increase the stability of actual oxygen 
therapeutics. However, the FILs with higher viscosity should not be selected because can 
present problems to promote dispersion of fluorinated compounds in the water and make 
difficult the intravenous administration of artificial blood substitutes. 
Mapping the behaviour of thermodynamic and thermophysical properties, it can be 
conclude that [EtMeIm][(PFBu)SO3] and [EtMepy][(PFBu)SO3] are a good election because 
it has a viscosity and a density similar to that of PFC-based emulsions and thus would not 
present any problems in the preparation or stability of the emulsion. However, these FILs 
present lower values of molar free volume than other FILS, which might be hindered the 
solubility of respiratory gases. Nevertheless, the fluorinated domains of these emulsions are 
expected to increase with the addition of these FILs, increasing the capacity for solubilizing 
respiratory gases. On the other hand, [EtMeIm][(CF3)CO2] present a good candidate for 
biomedical applications, because are very stable at a wide range of temperatures, has a high 
fluidity and show a behaviour very similar to ideal electrolyte. However, it present the 
smallest number of fluoro atoms indicating that it is impossible the formation of a fluorinated 
nanodomains. It is expected that the fluorinated alkyl chain present in FILs will also control 
the formation of these fluorinated nanodomains easing the accommodation of fluorinated 
solutes (gases or liquids) (Almantariotis et al. 2010; Bara et al. 2009; Muldoon et al. 2007). In 
this sense, it is expected that the length of the alkyl chain will also play a role on the 
aggregation. 
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2.2 Cytotoxicity of Fluorinated Ionic Liquids 
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2.2.1.Introduction 
The development of a new product for biomedical applications requires the execution 
of several processes until the commercialization. The first step passes through the research 
and development of the product. Since toxicological effects of ILs are not well known, the 
screening of cellular toxicity for some FILs need to be addressed (Ranke et al. 2007) with aim 
to accomplish our goal of develop an artificial blood substitute with fluorinated ionic liquids 
and to other possible biomedical applications. This screening is important not only for predict 
in vivo toxicity from in vitro studies but it also provides important information about the 
possible mechanism of action involved in toxicity (Malhotra and Kumar 2010).  
Recent studies report the influence of cation and anion in the toxicity of the ionic 
liquids and most of these publications establish parameters to predict the cytotoxicity (García-
Lorenzo et al. 2008; Kumar et al. 2008; Pereiro et al. 2013; Petkovic et al. 2011; Ranke et al. 
2007). However, just one article performed in our laboratory refer the toxicity of this specific 
family of ionic liquids, the fluorinated ionic liquids (Pereiro et al. 2013). Due to the scarce 
information available, the study of the toxicity and biocompatibility of these fluorinated ionic 
liquids will be very useful for their application in numerous fields, such as biomedical 
applications.  
In this work, cytotoxicity tests were carried out to determine dose-dependent toxicity 
curves and the concentration of sample necessary to decrease 50% of cell viability (cytotoxic 
effective concentration, EC50 value) for each FIL using the MTS colorimetric cytotoxicity 
assay. These tests were performed using four different human cell lines: human colon 
carcinoma cells, Caco-2; human hepatocellular carcinoma cells, HepG2; spontaneously 
immortalized human keratinocyte cell line, HaCaT; and human umbilical vein cell line, 
EA.hy926.  
Caco-2 cells were chosen for this work since these cells represent a prototype of the 
human epithelial cells, and they are commonly used as physiological model for intestinal 
transport and toxicity studies (Engle, Goetz, and Alpers 1998; García-Lorenzo et al. 2008; 
Sambuy et al. 2005). Other reports regarding ILs and some FILs from our studies use this 
model and then comparisons take into account Caco-2 cells can be achieved in this work. 
HepG2 cell was also used by other authors to determine the toxicity of the compounds due to 
the fact that this model preserves both liver-specific functions and morphology over  
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prolonged periods of time and have a metabolic capacity higher than Caco-2 (Pereiro et al. 
2013; Wilkening, Stahl, and Bader 2003). The selection of EA.hy926 and HaCaT cell lines is 
related to the goal of the project, development of artificial blood substitutes based on 
fluorinated ionic liquids. In this biomedical application, FILs are incorporated in new 
improved oxygen therapeutic emulsions with aim to replace, totally or in part, the inert PFCs 
presently used as oxygen carriers in these emulsions. Since administration of emulsion is 
intravenous, the evaluation of toxic profile in skin layers is mandatory. Keratinocytes (HaCaT 
cells) are the predominant cell type in the epidermis, constituting 95% of the cells found there 
(Rousselle et al. 2009). The endothelial cells (EA.hy926) belong to blood vessels and this 
type of cells coats the inside of blood vessels, particularly blood capillaries, forming part of 
its wall. When artificial blood substitute is administrated, the FILs-based emulsions will be in 
contact with blood vessels and the diffusion of respiratory gases will also occur here. Then, it 
is expected that the compounds, FILs and FILs-based emulsions, presents no toxicity in 
endothelial cells. The cytotoxic study was carried out using EA.hy926 cell line which is one 
of the most used and best characterized human vascular endothelial cell lines (Bouïs et al. 
2001; Wei et al. 2010). 
Some parameters like the concentration tested, exposure time, the media composition, 
the ion-pairing or other possible synergetic effects, like the model of mixture toxicity (where 
the individual compounds, cation and anion, will exhibit similar or different modes of action, 
leading to concentration dependent or independent mode of action, respectively), interactions 
between the compound and the cells could also occur and could influence the final response. 
 Finally, the complexity of living organisms and all the physical and biochemical 
processes that simultaneously occur could also interfere with toxicity mechanism of action 
(Petkovic et al. 2011). Then, it is important to highlight that this study shows results with 
different variants that must be considered. The information obtained in this work allows us to 
predict the behaviour of the ionic liquids taking into account the own characteristics of FILs, 
the characteristics of the living model studied and the parameters established for the assay, 
like exposure time. 
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2.2.2 Materials 
Tetrabutylammonium perfluorobutanesulfonate, >97% mass fraction purity, (2 
hydroxyethyl)trimethylammonium perfluorobutanesulfonate, >97% mass fraction purity, 1-
butyl-1-methylpyrrolidinium perfluorobutanesulfonate, 98% mass fraction purity, 1-ethyl-3-
methylpyridinium perfluorobutanesulfonate, >97% mass fraction purity, 1-ethyl-3-
methylimidazolium perfluorobutanesulfonate, >97% mass fraction purity, 1-hexyl-3-
methylimidazolium perfluorobutanesulfonate, >99% mass fraction purity; 1-ethyl-3-
methylimidazolium perfluorooctanesulfonate, >98% mass fraction purity; (2-
hydroxyethyl)trimethylammonium bis(nonafluorobutylsulfonyl)imide, >97% mass fraction 
purity were acquired at Iolitec. The purity of the commercial ionic liquids was checked by 
1
H-
NMR. 
1-Ethyl-3-methylimidazolium perfluoropentanoate was synthesized in Molecular 
Thermodynamic Lab by ion exchange resin methods, as develop by Ohno et al (Fukumoto, 
Yoshizawa, and Ohno 2005).  The purity of the final products was checked by 
1
H, 
13
C and 
19
F 
NMR and elemental analysis. 
All fluorinated ionic liquids were dried under vacuum (3.10
-2
 Torr) and vigorous 
stirring at 323.15K for at least 2 days, immediately prior to their use. This step is crucial in 
order to reduce volatile reduce volatile impurities, as well, as water, which can influence the 
ionic liquids properties. The water content, determined by Karl Fisher titration, was less than 
100 ppm for all the studied ionic liquids. No further purification was carried out. Structures 
and acronyms of all fluorinated ionic liquids are shown in Table 2.7.  
 
 
 
Table 2.7.- Chemical structure and respective abbreviation of fluorinated ionic liquids in study. 
FIL designation Chemical Structure 
Tetrabutylammonium 
perfluorobutanesulfonate 
[NBu4][(PFBu)SO3]  
(2-hydroxyethyl)trimethylammonium 
perfluorobutanesulfonate 
[NM3(EtOH)][(PFBu)SO3] 
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FIL designation Chemical Structure 
1-Butyl-1-methylpyrrolidinum 
perfluorobutanesulfonate 
[BuMepyr][(PFBu)SO3]  
1-Ethyl-3-methylpyridinium 
perfluobutanesulfonate 
[EtMepy][(PFBu)SO3]  
1-Ethyl-3-methylimidazolium 
perfluobutanesulfonate 
[EtMeIm][(PFBu)SO3]  
1-Hexyl-3-methylimidazolium 
perfluorobutanesulfonate 
[HexMeIm][(PFBu)SO3]  
1-Ethyl-3-methylimidazolium 
perfluorooctanesulfonate 
[EtMeIm][(PFOc)SO3] 
 
(2-Hydroxyethyl)trimethylammonium  
bis(nonafluorobutylsulfonyl)imide 
[NM3(EtOH)][NNf2] 
 
1-Ethyl-3methylimidazolium 
perfluoropentanoate 
[EtMeIm][(PFBu)CO2]  
 
For cell culture, human colon carcinoma cells, Caco-2, were purchased from Deutsche 
Sammlung von Mikroorganismen und Zellkulturen(DSMZ; Germany), human hepatocellular 
carcinoma cells, HepG2, were obtained from the European Collection of Cell Culture 
(ECACC; UK), spontaneously immortalized human keratinocyte cell line, HaCaT, were 
purchased from Cell Lines Service GmbH(CLS; Germany), and human umbilical vein cell 
line, EA.hy926, were purchased from American type Culture Collection (ATCC, USA). Cell 
culture medium , RPMI 1640 medium, MEM medium, DMEM medium and supplements,  
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fetal bovine serum (FBS), L-Glutamine, penicillin-streptomycin solution, MEM nonessential 
amino acids (MEM-NEAA), sodium pyruvate and trypsin-EDTA solution were purchased 
from Gibco (Invitrogen Corporation, Paisley, UK). 
For the in vitro cytotoxicity assays, CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay was purchased from Promega (CA, USA) 
 
 
2.2.3 Experimental Procedure 
In the cell culture, human colon carcinoma cells, Caco-2, were routinely grown in 
RPMI medium 1640 supplemented with 10% of inactivated fetal bovine serum (FBS), 2mM 
of glutamine and (1%) of penicillin-streptomicin. Human hepatocellular carcinoma cells, 
HepG2, were cultured in MEM medium with 10% of inactivated FBS, 2mM glutamine, 1% 
MEM-NEAA and 1% sodium pyruvate. Spontaneously immortalized human keratinocyte cell 
line, HaCaT, were routinely grown in DMEM medium supplemented with 10% of FBS, 2mM 
of glutamine, 1% of penicillin-streptomicin. Finally, human umbilical vein cell line, 
EA.hy926, were routinely grown in DMEM medium supplemented with 10% FBS and 1% of 
penicillin-streptomicin. Cells were kept at 37 ºC in a humidified incubator with 5% CO2 and 
routinely grown 175 cm
2
 culture flasks. The cell lines were split once or twice a week, the 
morphology and growth of cells were monitored daily. 
Caco-2 cells were seeded at a density of 2x10
4 
cells per well, in 96-well plates and 
their media was replaced every 48 hours. The experiments were performed using cells after 
reaching confluence, 96 hours after seeding. HepG2 cells were seeded at a density of 6x10
4
 
cells per well and experiments were performed at a confluence of 80%, 24 hours after 
seeding. HaCaT cells were seeded at a density of 1x10
4
 cells per well and experiments were 
performed at a confluence of 90%, 24 hours after seeding. EA.hy926 cells were seeded at a 
density of 2x10
4
 cells per well and experiments were performed after reaching confluence, 24 
hours after seeding.
 
Stock solutions of the FILs were prepared in dimethyl sulfoxide (DMSO), the FILs 
were studied in different ranges of concentrations due to the poor solubility of some of them 
in cell culture medium. All the ILs were homogenous in solution and diluted in 0.5% FBS 
culture medium with a maximum of 1% DMSO. All cell lines were incubated for 24 hours 
with the FILs in a 0.5% FBS medium. 
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Positive control cells were prepared containing culture medium with the minimum 
percentage of DMSO used (1% DMSO) and negative control cells were prepared containing 
only DMSO. After 24 hours of incubation, the samples were removed and 100 μl of a 
CellTiter 96® AQueous One Solution Cell Proliferation Assay reagent (containing MTS and 
PES) was added to each well and left to react for 4 hours. This solution reagent contains a 
tetrazolium compound (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS) and an electron-coupling reagent, phenazine 
ethosulfate (PES). PES has an enhanced chemical stability which allows it to be combined 
with MTS, leading to a stable solution. MTS is bio-reduced by cells into a coloured formazan 
product by mitochondrial reductase enzymes active in viable cells, thus the amount of 
formazan product that is soluble in tissue culture medium, is proportional to the number of 
viable cells. Formazan was quantified spectrophotometrically at 490 nm in a BioTek FLx800 
microplate reader (BioTek, USA). Each sample was incubated in three different wells and the 
obtained value was the average of three independent assays. Cell viability was determined by 
the ratio between the measured absorbance of FILs-contacted cells and the measured 
absorbance of control cells with 99% of cellular medium. Dose-dependent toxicity curves 
were determined presenting the toxicity trends for each FIL. The concentration of sample 
necessary to decrease 50% of cell viability (cytotoxic effective concentration, EC50 value) 
were obtained from dose-response curves using the GraphPad Prism (GraphPad Software, 
Inc., La Jolla, CA) software. 
 
 
2.2.4 Results and Discussion 
The information about the toxicity and biocompatibility of fluorinated ionic liquids is 
of crucial importance for all applications that incorporate ionic liquids, biomedical 
applications especially. There are only one publication in literature for Caco-2 and HepG2 
performed in our lab using fluorinated ionic liquids (Pereiro et al. 2013) but was only carried 
out assays with 4 h of exposure (digestion time). It is important to emphasize that, to our 
knowledge there are as yet no cytotoxicity data for fluorinated ionic liquids in HaCaT and 
EA.hy926. The combination of data from literature and the experimental measurements of 
this work will provide the useful information to choose the best fluorinated ionic liquid for 
biomedical applications, such as artificial blood substitutes. 
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The toxicity profiles, Figures 2.12-2.17, and the EC50 values, Table 2.8, calculated for 
FILs studied in this work were analysed taking into account the following parameters: the cell 
line, the difference between sulfonate and carboxylate FILs, the increment of hydrogenated 
chain length, the increment of fluorinated chain length, the nature of cation and the nature of 
anion. 
Table 2.8 - Cytotoxic effective concentration (EC50) values for fluorinated ionic liquids in cells 
 Log EC50 
FIL designation CaCo-2 HepG2 EA.hy926 HaCaT 
[NBu4][(PFBu)SO3] >4 >4 >4  
[NM3(EtOH)][(PFBu)SO3] >4 3.98 >4  
[BuMepyr][(PFBu)SO3] >4 >4 >4  
[EtMepy][(PFBu)SO3] >4 3.88 >4 3.85 
[EtMeIm][(PFBu)SO3] >4 >4 >4 3.82 
[HexMeIm][(PFBu)SO3] 3.84 >4 3.81 3.32 
[EtMeIm][(PFOc)SO3] 2.18 1.90   
[NM3(EtOH)][NNf2] 1.74 1.83   
[EtMeIm][(PFBu)CO2] >4 >4   
 
By analysis of the experimental toxicity profiles (Figure 2.12) for two different  
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families of cations, pyridinum [EtMepy]
+
 and imidazolium [EtMeIm]
+
 with the same anion, 
[(PFBu)SO3]
¯ 
in the four cell lines studied in this work, Caco-2, HepG2, EA.hy926 and 
HaCaT, it is possible to obtain the following conclusions: HaCaT cell line shows a drastically 
decrease in cellular viability since the lower concentration. A possible explanation to this 
behaviour in both ionic liquids is related to the hypothesis that HaCaT cells have lost some of 
their protection mechanism against DNA-damage through mutation of the p53 gene in vivo 
(Rekus 2000). If these ionic liquids cause DNA damage, in absence of that protection 
mechanism, cells could lose her viability until death. The EC50 values reported in Table 2.8 
for HaCaT reveal the toxicity behaviour of the compounds in this cell line which can be 
considered the most sensitive one. 
 
In general, the toxicity of these FILs, [EtMepy][(PFBu)SO3] and [EtMeIm] 
[(PFBu)SO3], was similar in the studied cell lines, with EC50 values upper 10000µM (Table 
2.8).The exception was found for HaCaT cell line and for [EtMepy][(PFBu)SO3] in HepG2. 
The toxicity of pyridinium in HepG2,with a EC50 value equal to 7586 µM (Table 2.8), shows 
an opposite behaviour to the other lines (the same ionic liquid shows high viability in Caco-2 
and EA.hy926) because this cell line has a higher metabolic capacity than other cell lines. In 
this case, the toxicity could be linked to the low expression of some phase I enzymes in this 
cellline which could be involved in the metabolism of pyridinium compound (Pereiro et al. 
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2013; Wilkening et al. 2003). A comparison between ionic liquids based on [(PFBu)SO3]
¯
 
sulfonate and carboxylate [(PFBu)CO2]
¯
 anions with the same imidazolium cation, 
[EtMeIm]
+
, for Caco-2 and HepG2 cell lines (EC50 values from Table 2.8, upper than 
10000µM and the experimental toxicity profiles from Figure 2.13) shows that both ionic 
liquids in both cell lines are viable in the range of concentrations studied. Only, a slight 
difference between the carboxylate and sulfonate anion can be observed in Caco-2 cells, a 
decrease of 20% of viability for the sulfonate anion (Figure 2.13).  
The increment of hydrogenated chain length in imidazolium cation, from [EtMeIm]
+
to 
[HexMeIm]
+
 for the same anion [(PFBu)SO3]
¯
, shows a descent of the viability in all cell 
lines. This information is supported by the analysis of toxicity profiles (Figure 2.14) and EC50 
values (Table 2.8).The same behaviour is observed in previous published reports with these 
same cations (García-Lorenzo et al. 2008; Pereiro et al. 2013; Ranke et al. 2004). Despite that 
the increment of the hydrogenated alkyl chain do not significantly change the cell viablility in 
HepG2 cell line, in other cell lines [HexMeIm]
+
 cation decrease drastically cellular viability.  
 
 
 
 
In the case of Caco-2 cell, viabilities are around 90% to 80% in all range of studied 
concentrations (500 µM to 10000µM) for [EtMeIm]+ cation. However, when the 
hydrogenated chain increases, the viability decrease until a cell viability of 20% in the highest 
concentration, 10000 µM, for example the case of [HexMeIm]
+ 
cation. This ionic liquid has 
Figure 2.14 - Effect of the increment of hydrogenated length chain in Caco-2, 
HepG2, EA.hy926 and HaCaT cell lines 
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an EC50 value of 6918 µM (Table2.8) consistent with the toxicity curve shown in Figure2.14. 
For EA.hy926 cells, FILs based on [EtMeIm]
+
 cation show that the viability drops from 100% 
to 80%, between 500 µM and 10000µM. However, the viability of [HexMeIm]
+
 sharply 
decreases until 5% in higher concentration, 10000 µM. This ionic liquid has an EC50 value of 
6457µM (Table 2.8) consistent with the toxicity curve shown in Figure 2.14. In HaCaT, both 
ionic liquids show a toxicity profile, however in the presence of [HexMeIm]
+
 the EC50 value 
decreases to 2089µM while in [EtMeIm]
+
 the EC50 is around 6606µM.  
Through the obtained results (Table 2.8, Figure 2.12, Figure 2.14 and Figure 2.16) it 
is possible to conclude that the toxicity profile for FILs with short hydrogenated alkyl chains 
depends on the nature of the cation and the anion. However, the cellular viability decreases in 
both compounds with longer hydrogenated chains. In the HepG2 cell line this decrease is 
almost insignificant whereas for other cell lines like Caco-2, EA.hy926 and HaCaT this 
descent is linked to a sharp decline in cellular viability. However the cytotoxicity of ionic 
liquids should be measured accordingly to the system, cation-anion, and not only based on the 
summation of the effects of cation and anion. The information obtained in this study could be 
a tool for the design of the pretended ionic liquid, but other aspects associated to 
thermophysical properties should be also considered. 
Some previous reports studied the  anion influence in the toxicity of ionic liquids in 
different cell lines. However just one report performed in our lab, evaluated the increase of 
the fluorinated alkyl chain length, from [(PFBu)SO3]
¯
 to [(PFOc)SO3]
¯
 for FILs based on the 
amonium cation with Caco-2 cell line (Pereiro et al. 2013) during 4 hours of exposure 
(digestion time). 
In this work, the increment of fluorinated alkyl chain was studied for the anions mentioned 
above, but for FILs based on imidazolium cation,[EtMeIm]
+
. The examination of Figure 2.15 
shows that for different cell lines, Caco-2 and HepG2, the increment of fluorinated alkyl chain 
leads to an increase in cells toxicity. These results are agreed with those previously obtained 
for the ammonium cation. Due to the poorly solubility of [(PFOc)SO3]
- 
anion in cell culture 
medium, the range of tested concentrations was slightly different for the both FILs in this 
study. In the case of FILs based on [(PFBu)SO3]
¯
, the studied concentrations range was 
between 500µM and 10000 µM, whereas that for [(PFOc)SO3]
¯
 anion, the range of 
concentrations varies from 4µM to 1000 µM in both cell lines. A reduction in order of 250 
times in concentration of FILs was carried out in the last FILs to obtain an identical behaviour 
in cytotoxic profiles, with viability close to 100% in Caco-2 and HepG2 cell lines. And then 
the EC50 values were calculated and a value of 150µM was obtained for Caco-2 cells and of 
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79 µM for HepG2 cells. This increasing in toxicity with the increment of the fluorinated chain 
could be linked to the formation of free fluoride ions, by hydrolytic cleavage. These chemical 
species may exhibit a high intrinsic reactivity leading to cytotoxic effects. Once they are 
potent inhibitors of Na
+
-K
+
-ATPase located at the cells surface and could influence cellular 
mechanisms, leading them to death (Kumar et al. 2008). On the other hand, the increment of 
cytotoxicity could be also linked to the increment of hydrophobicity of FIL when the 
fluorinated alkyl chain increases (Petkovic et al. 2011; Ranke et al. 2004). 
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Figure 2.16 - Cell viability of different cation families in Caco-2, HepG2, EA.hy926 and HaCaT 
cell lines 
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In order to select the fluorinated ionic liquid with less toxicity in human cell lines, the 
evaluation of the cation is an essential factor. In this work five different cations, ammonium, 
cholinium, pyrrolidinium, pyridinium and imidazolium were studied for Caco-2, HepG2 and 
EA.hy926 cell lines and the experimental results are plotted in Figure 2.16. Some studies 
were 
published indicating the toxicity of these cations, however there is no information in 
endothelial cell lines (Frade et al. 2009; García-Lorenzo et al. 2008; Petkovic et al. 2011). 
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Due to the poor solubility of ammonium cation, the range of studied concentrations for this 
ionic liquid is different to the others, from 380µM to 1513µM.By the analysis of experimental 
data in (Figure 2.16), it can be showed that in Caco-2 cells none of the studied compounds are 
toxics in the range of concentrations studied. All ionic liquids present values of cellular 
viability around 100% in lower concentrations and 80% in higher concentrations. Despite the 
similarity of the curve- dose response in all ionic liquids, these data are according with the 
previous studies presents in literature where the minor toxicity to cholinium and 
pyrrolidinium cation is demonstrated (Frade et al. 2007; Petkovic et al. 2011).  
Furthermore, FILs based om imidazolium and pyrrolidinium cations present cellular 
viability in all range of studied concentration. The FIL based on ammonium cation shows 
100% of cellular viability in all possible studied concentrations (miscible composition range), 
but all FILs also shows same values of cellular viability in this same range of concentrations. 
However, cholinium cation ([NM3(EtOH)]
+
) described as one of the less toxics cations (Frade 
et al. 2007; Petkovic et al. 2011; Weaver et al. 2010) shows an EC50 value of 9550 µM for this 
cell line. Pyrridinium cation also shows some toxicity in this cell line with an EC50 value of 
7586 µM. These results also suggest a dependence between the exposure time and the 
toxicity, since that all cation families in a exposure time of 4 hours did not induce any toxicity 
for the highest concentrations, 10000 µM (Pereiro et al. 2013), this same conclusion was 
reported in previous studies and in our lab (Pereiro et al. n.d.; Petkovic et al. 2011). The 
results from EA.hy926 are similar to those seen in Caco-2 cells, in these cell lines no toxicity 
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was registered and the higher viability is verified with cholinium cation, followed by 
pyrrolidinium cation.  
The effect of the anion in cellular viability is apparently secondary compared to the 
cation, and it is more evident for the less toxic cations (Petkovic et al. 2011). In this study, 
cholinium cation, one of the less toxic described in literature, was tested with two different 
anions, [(PFBu)SO3]
¯
 and [NNf2]
¯
, Figure 2.17. The fluorinated nature of these anions makes 
them the very lipophilic and/or unstable and this characteristic play a major role in 
cytotoxicity of these FILS, due to the formation of fluoride ions by hydrolytic cleavage 
(Kumar et al. 2008; Petkovic et al. 2011) and then the increment of hydrophobicity. When the 
fluorinated domains increase significantly, a drastic decrease in the cell viability is reported. 
This effect can be verified in the case of [NNf2]
¯
anion when it is compared with [(PFBu)SO3]
¯
 
anion in both cell lines . Besides, the [NNf2]
¯
 anion decreased the solubility of cholinium 
cation in cellular medium and a lower concentration range was tested, from 4µM to 1000µM. 
This ionic liquid, [NM3(EtOH)] [NNf2], presents EC50 values of 55µM and 68µM for Caco-2 
and HepG2 cells, respectively. Besides, this anion is much more toxic than [(PFBu)SO3]
¯
 
which  is viable in all range of studied concentrations, 500µM to 10000µM, for Caco-2 cells. 
In the case of HepG2 cells, this last anion, [(PFBu)SO3]
¯
, displays a high EC50 value, 
9550µM.  
 
2.2.5 Conclusion 
All the results that were experimentally determined in this work contribute to better 
understand the behaviour of FILs in human cell lines . Furthermore, these studies represent an 
increasing in data bases for FILs that are still very scarce in the literature. In this study, it was 
demonstrated the toxicity of FILs based on two different cations families, imidazolium and 
pyridinium, in HaCaT cell lines. This toxicity could be linked to the own characteristics of the 
cell line. However, some future studies should be carried out, because these imidazolium 
(with short alkyl chain length) and pyridinium cations show lower toxicity in the others cell 
lines (Caco-2, HepG and HaCaT). More studies should be done in this line in order to better 
understand the cell death mechanisms and who it could be solved. Cations like cholinium and 
pyrrolidinium should be also tested for HaCaT due to their low toxicity in other cell lines. 
Artificial blood substitutes are marketed in the form of emulsions which will be into contact 
with all the skin layers. Cytotoxicity assays in keratinocytes cells such as HaCaT cell line 
should be studied in order to support this information. 
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On the other hand, it can be concluded that the difference between sulfonate and 
carboxylate anions is insignificant. The increment of the hydrogenated and fluorinated alkyl 
chain length is related to an increment of toxicity. Furthermore, the cations with lower 
toxicity profile are cholinium and pyrrolidinium. However, pyridinium cation and 
imidazolium with short hydrogenated chain also present good results when are combined with 
[(PFBu)SO3]
¯
anion. 
Taking all results into account, the best ionic liquids for the development of new 
artificial blood substitutes based on fluorinated ionic liquids are [BuMepyr][(PFBu)SO3], 
[NM3(EtOH)][(PFBu)SO3], [EtMepy][(PFBu)SO3] and [EtMeIm][(PFBu)SO3]. Finally, after 
the choice of the FILs, it should be explain that cytotoxicity studies of the final product 
(emulsion of water + PFC + FIL in the best formulation) will be needed in order to evaluate 
the viability of these products in biomedical market. 
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2.3. Partition properties of Fluorinated Ionic 
Liquids 
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 72 
 
  
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 73 
 
 
 
2.3.1.Introduction 
One of the most important parameter in pharmacological and toxicological 
research is the partitioning of a chemical, also known as hydrophobic/hydrophilic 
balance, which is used to model blood / lipid partition (Lee and Lee 2009).  
This parameter is mandatory to understand the ecological effects of fluorinated 
ionic liquids, but it is also important to evaluate the tendency of a chemical to cross 
biological membranes and to understand their behaviour in vivo. This information is 
correlated with the differences in thermophysical properties, bioviability as well as 
toxicity and half-life features (Florindo et al., 2013). 
The octanol-water partition coefficient (Kow) is the most common method to 
access the hydrophobic/hydrophilic balance of a compound, due to the characteristics of 
octanol (organic solvent) that mimics the biological membranes (Florindo et al. 2013). 
By definition, the activity of a compound in the water-rich phase and in the 
octanol-rich phase must be the same when equilibrium is reached. If the compound is 
sufficiently dilute in both phases, it can be considered at “infinite dilution”, namely 
extremely dilute concentration (Ci). In these conditions, the activity coefficients should 
not change even with small variation in the concentrations. The Kow value were 
calculate through de ratio between the concentration of the test compound in octanol 
phase( ) and the concentration of compound in water phase ( ) (Ropel et al. 2005) 
Kow =   (2.12) 
The most common methods to determine Kow are estimation by high 
performance liquid chromatography (HPLC), the generator column method, the “Shake 
Flask” and “Slow Stirring” method (Florindo et al. 2013; Ropel et al. 2005; Sangster 
1989) In the HPLC technique, the retention time of the compound is compared with 
chemical references. However this type of measurement should only be used for Kow 
values greater than one. For generator column method, water presaturated with octanol 
is slowly passed through a column which is packed with a solid support that has been 
coated with octanol containing a small amount of the test chemical. The liquid solution 
leaving the column is assumed to be in equilibrium with the octanol on the packing. The 
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 74 
 
analysis of aqueous phase provides the Kow value. However, some error could occur due 
to the interaction between the test chemical and the column packing. In “Shake Flask” 
method, the sample is vigorously stirred for approximately 1 hour at a constant 
temperature, 25ºC, the adequate amount of time for the equilibrium to be reached. Some 
errors can be detected due to the presence of microdroplets of octanol in water (Ropel et 
al. 2005). 
In this study, the measurements were made with Slow Stirring method. In this 
method, after the pre-saturation of octanol and water and vice versa, a small amount of 
test chemical is mixed with octanol saturated. Then this mixture and the same volume of 
water saturated in octanol are placed in a glass vial. The sample is stirred slowly to 
minimize the stagnant diffusion layer between the phases while preventing 
emulsification. When the concentrations in each phase have stabilized, the chemical 
concentrations are measured in each phase to determine the Kow. This method had the 
advantage to evaluate the diffusion of the compound during the time with diverse 
samplings (Ropel et al. 2005).The choice of this method is also related to the reliability 
of the method. Furthermore, a verification with the reported results on literature for 
conventional ionic liquids similar to FILs (ionic liquids based on 
bis(trifluoromethylsulfonyl)imide) confirms that this methods is the best for the study of 
FILs. 
 
2.3.2.Materials 
1-Ethyl-3-methylpyridinium perfluorobutanesulfonate, >97% mass fraction 
purity, 1-ethyl-3-methylimidazolium perfluorobutanesulfonate, >97% mass fraction 
purity, 1-hexyl-3-methylimidazolium perfluorobutanesulfonate, >99% mass fraction 
purity, 1-mehtyl-3-octylimidazolium perfluorobutanesulfonate,], > 98% mass fraction 
purity, 1-ethyl-3-methylimidazolium perfluorooctanesulfonate, >98% mass fraction 
purity were acquired at Iolitec. The purity of the commercial ionic liquids was checked 
by 
1
H-NMR. 
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1-Ethyl-3-methylimidazolium perfluoropentanoate was synthesized in Molecular 
Thermodynamic Lab by ion exchange resin methods, as develop by Ohno et al 
(Fukumoto, Yoshizawa, and Ohno 2005). The purity of the final products was checked 
by 
1
H, 
13
C and 
19
F NMR and elemental analysis.  
 All fluorinated ionic liquids were dried under vacuum (3.10
-2
 Torr) and 
vigorous stirring at 323.15K for at least 2 days, immediately prior to their use. This step 
is crucial in order to reduce volatile reduce volatile impurities. Structures and acronyms 
of all fluorinated ionic liquids are shown in Table 2.3.1. 1-Octanol ACS reagent, 
 purity, was acquired at Sigma-Aldrich and Milli-Q ultrapure water (Milli-Q 
Integral Water Purification System) was used in all experiments throughout the work.  
 
Table 2.9 - Chemical structure and respective abbreviation of fluorinated ionic liquids in 
study. 
FIL designation Chemical Structure 
1-Ethyl-3-methylpyridinium 
perfluobutanesulfonate 
[EtMepy][(PFBu)SO3] 
 
1-Ethyl-3-methylimidazolium 
perfluobutanesulfonate 
[EtMeIm][(PFBu)SO3]  
1-Hexyl-3-methylimidazolium 
perfluorobutanesulfonate 
[HexMeIm][(PFBu)SO3]  
1-Mehtyl-3-octylimidazolium 
perfluorobutanesulfonate 
[OcMeIm][(PFBu)SO3]  
1-Ethyl-3-methylimidazolium 
perfluoroctanesulfonate 
[EtMeIm][(PFOc)SO3] 
 
1-Ethyl-3methylimidazolium 
perfluoropentanoate 
[EtMeIm][(PFBu)CO2]  
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2.3.3.Experimental Procedure 
Slow Stirring Method  
The first step of process was the mutual saturation of solvents, Figure 2.18, 
octanol and water. An equal quantity of both substances was vigorously mixed and 
when two different phases (water saturated in octanol and octanol saturated in water) 
were distinguishable, approximately after 72 hours, the separation was made. 
 
 
 
 
In a glass vial, with an open top screw-cap sealed with a septum of silicone and a 
magnetic stir bar, approximately 5 mL of water saturated in octanol was added. The 
same volume of solution containing the mixture of FIL and octanol was added carefully 
to the vial, to prevent the emulsification of solutions. The starting concentration of FILs 
in octanol phase varied from 0.25  10
-3 
mol/L to 3.88  10
-3 
mol/L. 
To prevent the contamination during the sampling, a sealed syringe was inserted 
in the system before the addition of solution containing octanol and FIL.. The vials were 
stirred slowly to prevent emulsification and were maintained at room temperature (25  
2 ºC). Samples were taken from the water-rich phase at least three times in a period 
between 24 and 48 days. The sampling process is illustrated in Figure 2.19 and the 
systems are presented in Figure 2.20. The last sampling occurs when the concentrations 
in both phases were stabilized. At least three different concentrations were tested for 
each FIL 
Figure 2.18 – Mutual saturation of solvents, octanol and water. 
Octanol saturated in water 
Water saturated in octanol 
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After sampling, octanol-rich phase was centrifuged for 1 hour at 3270 rpm and 4
ºC using an Allegra® X-12R Centrifuge, Beckmn CoulterECKAMN COULTER, with 
aim to ensure the complete separation of residues that could come from water phase. 
This centrifugation also eliminates possible octanol micelles presents in the sample.  
The sampling occurs until the Kow values no longer changed with time. 
Concentrations of FILs were measured using UV-vis spectroscopy, model 
Shimadzu UV-1800, Pharma-Spec spectrophotometer, illustrated in Figure 2.20, at 
specific wavelengths (see Table 2.10) since this technique detects the aromatic ring on 
the cation. The uncertainty of the method is around 1%  
 
Table 2.10 - λmax of FILs used for absorbance determination 
FIL designation λmax in water/nm λmax in octanol/nm 
[EtMepy][(PFBu)SO3] 265 266 
[EtMeIm][(PFBu)SO3] 211 211 
[HexMeIm][(PFBu)SO3] 211.5 210.5 
[OcMeIm][(PFBu)SO3] 212 212.5 
[EtMeIm][(PFOc)SO3] 212 211 
[EtMeIm][(PFBu)CO2] 210.5 211.5 
 
Figure 2.19 – Slow Stirring method, with samples at 25ºC  
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Samples were diluted in order to obtain absorbance values less than 1. For 
quantification in water phase the reference cell contained water saturated with octanol. 
However, for quantification in octanol phase the reference cell is filled with octanol 
saturated in water. The Kow was measured at very dilute concentrations with aim to the 
best representation of the concentrations of FILs in contact with organism, and to avoid 
the formation of micelles, which difficult the measurement of quantification . This 
experimental method was validated by measuring three different stock solutions of two 
conventional ionic liquids acquired at Iolitec, 1-butyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide and 1-octyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide, and comparing the results with previous literature 
values(brenecke). These commercial ionic liquids are the more similar to fluorinated 
ionic liquids, due to the number of fluoros in anion (bis(trifluoromethylsulfonyl)imide). 
 
2.3.4.Results and Discussion 
For biomedical applications, the behaviour of a chemical in contact with cell 
membranes is crucial. In this work, the Kow values of different FILs were measured with 
aim to determine the affinity of these compounds to cross the cell membrane. This 
capacity needs to be low for artificial blood substitutes in order to promote the transport 
of respiratory gases through blood vessels without entry in cells. In Table 2.11, the 
concentration of FILs in water phase is showed as also the respective Kow values. The 
uncertainty of the Kow value is  
 
Figure 2.20 – Shimadzu UV-1800 Pharma-Spec spectrophotometer  
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5%. This uncertainty could be linked to the variation in room temperature and to the fact 
that octanol and water form an emulsion that could lead to error in Kow measurements. 
Furthermore, the solubility of water in octanol at 25ºC is quite larger than octanol in 
water and that fact could influence the partitioning of FILs between two solvents (Ropel 
et al. 2005).  
Table 2.11 – Kow values and concentration of FIL in water phase 
FIL designation Kow 
Concentration range in 
water phase/mol L
-1
 
[EtMepy][(PFBu)SO3] 0.270 – 0.664 2.95 10
-3
 - 1.19 10
-4
 
[EtMeIm][(PFBu)SO3] 0.3195 2.98 10
-3
 - 2.44 10
-3
 
[HexMeIm][(PFBu)SO3] 4.27 7.07 10
-4
 - 5.23 10
-4
 
[OcMeIm][(PFBu)SO3] 7.68 2.44 10
-4
 
[EtMeIm][(PFOc)SO3] 2.96 – 4.35 2.5 10
-4
 – 1.87 10-4 
[EtMeIm][(PFBu)CO2] 0.513 – 0.889 2.84 10
-3
 – 1.82 10-3 
 
In general the final concentrations of FILs in water rich phase vary from 
1.87 10
-4
 molL
-1
 to 2.98 10
-3
 molL
-1
, Table 2.11. In octanol rich phase concentrations 
are between 6.17 10
-4
 and 3.30 10
-3
 molL
-1
. For [EtMeIm][(PFBu)SO3], 
[HexMeIm][(PFBu)SO3] and [OcMeIm][(PFBu)SO3] substantial differences in Kow 
values were not observed, then it can be concluded that the dilute limit was reached for 
these FILs.In the case of [EtMepy][(PFBu)SO3], [EtMeIm][(PFOc)SO3] and 
[EtMeIm][(PFBu)CO2] , Kow were slightly dependent of concentration, even at dilute 
regions, with concentrations less than 3.88 10
-3
mol/L. In this case Table 2.11 shows 
the range of Kow measured for the different concentrations. The same behaviour were 
verified in literature for some convencional ionic liquids (Ropel et al. 2005). In order to 
select the most appropriated FIL to develop an artificial blood substitute, the partition 
coefficients octanol-water must be analysed. The influence of the anion nature, 
carboxylate [(PFBu)CO2]¯ and sulfonate [(PFBu)SO3]¯  anions, in Kow value for FILs 
with the same imidazolium cation [EtMeIm]
+
 is shown in Figure 2.21. The analysis of 
the results for two FILs shows that the Kow values for [EtMeIm] [(PFBu)CO2] are 
approximately two times higher (0.684) than for [EtMeIm] [(PFBu)SO3] (0.320). This 
result suggests that the carboxylate anion increase the hydrophobicity of the compound. 
However, a comparison between these Kow values and the ones of some common  
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Figure 2.21 – Kow values for sulfonate and carboxylate anion 
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organic compounds like caffeine (0.85), benzene (135) and cyclohexane (2754) shows 
that both values of these FILs are lower (Ropel et al. 2005). As a consequence both 
FILs can be considered extremely hydrophilic. 
Another comparison was made in order to understand how the increment of 
hydrogenated length chain could influence the behaviour of FILs in contact with cell 
membranes (see Figure 2.22). Taking the analysis of results into consideration, it is 
possible to verify that the increment of the chain provides an increasing of Kow values.  
The obtained results are consistent with literature . In these papers, it was 
reported that solubility of imidazolium based ionic liquids in alcohols increases with 
alkyl chain length. These study sugest that greater van der Waals interactions between 
Figure 2.22 – Kow values due to the increment of hydrogenated length 
chain 
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FILs alkyl chain and octanol are responsible for this evidence (Ranke et al. 2007; Ropel 
et al. 2005).  
Accordingly to these results [OcMeIm][(PFBu)SO3] had a more hydrophobic 
behaviour than other imidazolium FILs showing an increasing of the ability of entry in 
cell membranes. 
Another parameter that should be evaluated is also the increment of fluorinated 
alkyl chain length, Figure 2.23. Taking into account the same imidazolium cation, 
[EtMeIm]
+
, the hydrophobicity of the FIL increases with the fluorinated alkyl chain 
length. In the case of [EtMeIm][(PFOc)SO3], the Kow value is much higher (3.15) than 
for [EtMeIm][(PFBu)SO3] (0.320). In a same way that happened with the increment of 
hydrogen alkyl chain, van der Walls interactions between FILs fluorinated chain and 
octanol could promote the linkage or interaction between the FIL and cell membrane 
facilitating the entry in the cells. 
 
In order to choose the best fluorinated ionic liquid, the cation nature was also 
evaluated (see Figure 2.24). Taking into account the same [(PFBu)SO3]¯ anion, 
imidazolium [EtMeIm]
+
 and pyridinium [EtMepy]
+
 cations were compared. Both ionic 
liquids are hydrophilic, with low Kow values and could be used for artificial blood 
substitutes. However [EtMeIm]
+
 cation is the most appropriate. As mentioned above, 
these FILs have a low Kow value in all range of studied concentrations whit values lower 
than some organic solvents. Kow values of [EtMepy]
+
 cation were slightly dependent of 
concentration even at very dilute concentrations. This is a disadvantage comparatively 
with [EtMeIm]
+
 cation.  
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Figure 2.23 – Kow values due to the increment of fluorinated length chain 
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Finally, to compare data of cytotoxicity assays and Kow values, Figure 2.25 
shows a possible correlation between the hydrophobicity/hydrophilicity of FILs and the 
EC50 values in Caco-2 cell line, cytotoxicity assays. The increasing of hydrophobicity, 
higher values of Kow, shows a decreasing in cell viability. These conclusions were in 
line with previous reports (Petkovic et al. 2011) . Furthermore, it is also possible to 
verify the influence of the increment in hydrogenated and fluorinated length chain in the 
Kow values and consequently in the corresponding cytotoxicity. With longer length 
chains, the affinity of compound to entry in cell increases as also the cytotoxicity. Take 
into account this conclusion, the most appropriate ionic liquid for our goal application is 
[EtMeIm] [(PFBu)SO3]. 
 
 
Figure 2.24 – Kow values for different cations families 
K
o
w
0.0
0.1
0.2
0.3
0.4
0.5
[EtMeIm][(PFBu)SO
3
]
[EtMepy][(PFBu)SO ]
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 83 
 
 
 
 
 
 
Biomedical Applications Using Fluorinated Ionic Liquids 
Fluorinated Ionic Liquids as Artificial Blood Substitutes 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 84 
 
2.3.5.Conclusion 
In order to select the most appropriate FIL to use in emulsions of artificial blood 
substitutes, several comparisons were made in this work. It was essential that blood 
substitutes kept in blood circulation to ensure the effective respiratory gases transport. 
Then, a hydrophilic behaviour plays an important role in this matter. This hydrophilic 
behaviour is connected with low Kow values showing that low Kow values are associated 
to a hydrophilic behaviour. The opposite behaviour was verified for higher values 
Taking the partition coefficient octanol-water into consideration, it was possible 
to conclude that imidazolium cation is the more hydrophilic cation. Besides, it was also 
confirmed that the increment of both hydrogentated and fluorinated alkyl chain length 
was a disadvantage because it increases the hydrophobicity of FILs. Also, sulfonate 
anions are more hydrophilic than carboxylate anions. 
Finally, taking all of these conclusions into account, [EtMeIm][(PFBu)SO3] is 
the most suitable FIL to be used in the development of artificial blood substitutes. 
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2.4. General Conclusion 
  
Biomedical Applications Using Fluorinated Ionic Liquids 
General Conclusion 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 86 
 
 
  
Biomedical Applications Using Fluorinated Ionic Liquids 
General Conclusion 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 87 
 
 
This work is part of a project focused on the development of a new and 
improved generation of artificial blood substitutes. Evaluations of several 
thermodynamic and thermophysical properties were carried out in order to select the 
most appropriate fluorinated ionic liquid to apply in this biomedical application. 
The target FIL should be stable and liquid at a considerable range of 
temperatures, human body temperature included (  37 ºC). Melting point was 
measured to determine the fusion temperature of these FILs. However, this value is not 
a limiting factor because the emulsion is also composed of water and perfluorocarbons, 
and the FIL could be solubilized in the corresponding emulsion. Fluorinated ionic 
liquids based on cholinium cation are an example of these compounds, their melting 
points cannot be determined because their decomposition temperature is lower than 
fusion temperature. However, the high solubility in water of these compounds makes 
them very useful.  
Density, fluidity, iconicity and ionic conductivity of FILs were also evaluated. 
One disadvantage of PFCs-emulsions used nowadays as artificial blood substitutes is 
their low stability. Fluorinated ionic liquids increase the viscosity of PFCs-emulsion 
leading to a higher stability. Nevertheless once that blood substitutes are intravenous 
administrated that increment should not exceed values of blood fluidity. Also free molar 
volume and the increasing of fluorinated domains in PFCs-emulsion was evaluated to 
better understand the capacity of FIL to solubilize respiratory gases. 
Another important factor is the toxicity of FILs in human cell lines. The results 
obtained provide us useful information to predict the less toxic anions and cations. 
Thus, it is possible to select the best FIL to apply in PFCs-emulsions. Several cell lines 
were evaluated at different concentrations. Expected concentrations of FILs in 
emulsions were lower than the tested for pure ionic liquids. Then, for biomedical 
applications, the highest concentrations linked to EC50 values will be never achieved. 
Finally, the ability of FILs to cross cell membranes was evaluated through 
octanol-water partition coefficients. This parameter is directly linked with cytotoxicity. 
More hydrophobic compounds lead to a decrease in cell viability. 
To sum up,  all parameters considered in this work show that some cations and 
anions should be discarded for the development of a new and improved generation of 
artificial blood substitutes. The thermophysical and thermodynamic properties together 
Biomedical Applications Using Fluorinated Ionic Liquids 
General Conclusion 
 
 
Master Thesis in Pharmaceutical Biotechnology, FFUC Page 88 
 
cytotoxicity tests show that [NNf2]¯ anion should be excluded due to its high toxicity, 
high melting point and lower solubility in water. The increment of fluorinated and 
hydrogenated chain were also evaluated and all these parameters proved to be a 
disadvantage. Some families of different cations were analysed and imidazolium and 
pyridinium present the best results to be used in PFCs-emulsions. However, the 
utilization of imidazolium is restricted to short hydrogenated and fluorinated alkyl 
chains. FILs based on pyrrolidinium cation are also one of less toxic, but these FILs are 
practically insoluble and the high melting point is also a limiting factor. Cholinium 
cation is a good candidate too for biomedical applications due to its low toxicity and to 
its high water solubility described in literature (Araújo et al. 2014)Until now it can be 
conclude that pyridinium and cholinium cation, as also imidazolium with short 
hydrogenated chain are the most promising FILs when combined with 
perfluobutanesulfonate anion. However, more studies need to be done in order to evaluate 
the behaviour of PFCs-emulsions with FILs. 
Finally, to conclude, this chapter present new and important data for scientific 
community and for industrial application of fluorinated ionic liquids. Until this work, 
previous reports with fluorinated ionic liquids are extremely scarce. To our knowledge, 
the cytotoxicity of these compounds was only evaluated in one report with FILs are 
available in our laboratory that have been used in this work with aim to compare the 
different anions and cations. Besides, there are yet no octanol-water partition 
coefficients data for fluorinated ionic liquids, defined as ionic liquids with fluorine tags 
equal or longer than four carbon atoms, in the open literature. This low number of 
previous reports reflects the innovative character of this study based on neoteric 
fluorinated ionic liquids. Furthermore, these experimental results provide relevant 
information for other biomedical applications. 
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3.1.Introduction 
Likewise as was mentioned in general introduction section, the use of ionic 
liquids in pharmaceutical research is in exponential growing. The unique characteristics 
of ionic liquids could be used with a lot of active pharmaceutical ingredients to improve 
their pharmacological activity. This concept of pharmacological design enables the 
balance between the desired pharmacological effect and the reduction of adverse side 
effects (Florindo et al. 2013). Also physical properties required for industrial 
applications and pharmaceutical manufacturing could be managed (Ferraz et al.,2011). 
Some previous studies reinforce the potential of ILs to dissolve poorly soluble APIs, as 
well as biochemical compounds, such as DNA and nucleic acid bases(Ferraz et al. 2011; 
Hough et al. 2007)In this work, API-ILs, compounds with cholinium cation and 
different active pharmaceutical ingredients, nalidixic acid (NAL), niflumic acid (NIF) 
and pyrazinoic acid (PYR) were synthetized, characterized and their toxicity and 
bioavailability were also evaluated. Once that our goal is the development of an 
efficient drug delivery system, that increase the efficiency of the pattern active 
pharmaceutical ingredients. All of these studies were performed in comparison with 
parent active pharmaceutical ingredients, available in the market. 
First of all, the relevance of thermophisical behaviour for ionic liquids in 
biomedical applications was clarified. The addition of specific cations or anions leads to 
a modification in some properties of the original compounds. Melting and 
decomposition temperatures are crucial to determine the range of temperatures were 
APIs and API-ILs could be used at a liquid state without decompose. 
Secondly, toxicity data is of full importance to the implementation of a drug 
delivery system in the market. All potential pharmaceutical formulation need to pass by 
in vitro tests to predict the in vivo results until get approved for commercialization. 
These studies were performed in order to determine the cytotoxicity of API-IL 
comparatively with parent API in two human cell lines, namely Caco-2 and HepG2 
cells.  
Finally and to analyse the absorption of API-ILs and APIs in cell membranes, 
the hydrophobic/hydrophilic balance was measured by octanol-water partition 
coefficients through Slow Stirring Method. This parameter is related to the  
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thermophysical properties and influences the bioavailability of compounds as well as its 
toxicity and half-life features(Florindo et al. 2013). In contrast with artificial blood 
substitutes, for this delivery application, a hydrophobic character is desired once that to 
have a pharmacological effect the compound need to entry in the cell. 
Briefly, the goal of this work is to determine if the addition of cholinium in 
pharmaceutical active principles improves their therapeutic action. 
 
 
3.2.Materials 
3.2.1.Parent APIs, ILs and API-ILs 
Nalidixic acid, 98% mass fraction purity, niflumic acid, 98% mass fraction 
purity and pyrazinoic acid, 99% mass fraction purity were purchased from Sigma-
Aldrich. The parent APIs were used without further purification. Cholinium chloride 
((2-hydroxyethyl) trimethylammonium chloride), 98% mass fraction purity was 
purchased from Sigma-Aldrich. API-ILs were synthesized in Molecular 
Thermodynamic Lab by ion exchange resin method, as develop by Ohno et al 
(Fukumoto, Yoshizawa, & Ohno, 2005). The purity and structures of the final products 
was checked by 
1
H and 
13
C NMR, ESI mass spectra and elemental analysis. 
Ionic liquid was dried under vacuum (3.10
-2
 Torr) at 323.15 K for at least 2 days, 
immediately prior to their use. This step is crucial in order to reduce volatile impurities, 
as well as water, which can influence the ionic liquids properties. The water content, 
determined by Karl Fisher titration, was less than 500 ppm. The chloride content (halide 
impurities), quantified by Chloride Ion Selective Electrode, and was found to be less 
than 500 ppm. Chemical structure of APIs are available in General Introduction, Figure 
1.Whereas chemical structure and designation of API-ILs are summarized in Table 3.1 
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Table 3.1. Chemical structure and respective abbreviation of APIs and API-ILs in study 
Cholinium based API-IL Chemical Structure 
Cholinium nalidixate 
 
Cholinium niflumate 
 
Cholinium pyrazinate 
 
 
3.2.2.Toxicity Assay 
For cell culture, human colon carcinoma cells, Caco-2, were purchased from 
Deutsche Sammlung von Mikroorganismen und Zellkulturen(DSMZ; Germany), human 
hepatocellular carcinoma cells, HepG2, were obtained from the European Collection of 
Cell Culture (ECACC; UK). Cell culture medium , RPMI 1640 medium, MEM medium 
and supplements, fetal bovine serum (FBS), L-Glutamine, penicillin-streptomycin 
solution, MEM nonessential amino acids (MEM-NEAA), sodium pyruvate (100x) and 
trypsin-EDTA solution were purchased from Gibco (Invitrogen Corporation, Paisley, 
UK). 
For the in vitro cytotoxicity assays, CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay was purchased from Promega (CA, USA) 
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3.2.3.Partition Coefficients – Solvents 
1-Octanol ACS reagent,  purity, was acquired at Sigma-Aldrich and 
Milli-Q ultrapure water (Milli-Q Integral Water Purification System) was used in all 
experiments throughout the work.  
3.3.Experimental Procedure 
3.3.1.Thermal Properties 
Thermogravimetric analyses (TGA) were carried out with a TA instrument 
Model TGA Q50, shown in Figure 2.1, where the thermal stabilities and decomposition 
temperatures of the APIs and cholinium based API-ILs were measured. Experimental 
procedure was detailed in Section 2.1.2. Samples were placed inside of aluminium pans 
and heated to 873.15 K at a rate of 274.15 K until complete thermal degradation was 
achieved. 
A Differential Scanning Calorimeter (DSC), shown in Figure 2.2, was used to 
measure the thermal properties of the cholinium based API-ILs. Procedure was also 
detailed at Chapter 2, Section 2.1.2. Melting temperature was selected at a rate of 1 
ºC/min for cholinium nalidixate and cholinium niflumate and 5 ºC/min for cholinium 
pyrazinate. 
 
3.3.2.In vitro cytotoxicity assays 
Cell culture procedure for Caco-2 and HepG2 cells was described in Section, 
2.2.3 as well as MTS assay. The major difference between cytotoxicity studies with 
FILs and API-ILs is the range of tested concentrations. Due to poor solubility of APIs in 
cellular medium, all samples of APIs and API-ILs were firstly prepared in Milli-Q 
water and then the minimum dilution with culture medium was reached to avoid 
precipitation. Similar concentrations were tested for APIs and API-ILs in order to 
evaluate the influence of cholinium in cellular viability of these cell lines. 
 
3.3.3.Octanol-water partition coefficients 
Partition coefficients of APIs and API-ILs were measured according Slow 
Stirring method described in Section 2.3.3. For parent APIs and API-ILs, the started 
concentration in octanol phase varied from 0.007 g/L to 0.014g/L. Samples were 
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measured until 42 days, when the concentrations in both phases were stabilized. The last 
sampling occurs when the concentrations in both phases were stabilized. 
Glass vials with the samples were kept isolated of light, due to photosensitizer 
characteristic of nalidixic and niflumic acid. Concentrations of compounds in water 
phase were measured using UV-vis spectroscopy (Shimidzu UV-1800, Pharma-Spec 
spectrophotometer, Figure 2.20), at specific wavelengths, Table 3.2. 
 
Table 3.2 - λmax of APIs and API-ILs used for absorbance determination 
Parent API designation λmax in water/nm λmax in octanol/nm 
Nalidixic acid 285 258 
Niflumic acid 286 293 
Pyrazinoic Acid 268 268 
API- ILs designation λmax in water/nm λmax in octanol/nm 
Cholinium nalidixate 258 258 
Cholinium niflumate 287 293 
Cholinium pyrazinate 268 268 
 
3.4.Results and discussion 
3.4.1.Thermal properties 
With the analysis of melting and decomposition temperatures, it is possible to 
define the liquid range of the fluids and their range of application. The thermal 
properties (melting point, thermal stabilities, decomposition temperature and glass 
transition temperature) of API-ILs are presented in Table 3.1. Additionally, a 
comparison of melting temperatures with literature values for parent API is illustrated in 
Figure 3.1 (Araújo et al. 2014a; Bustamante et al. 2002). 
Table 3.3 – Melting temperature, Tm, decomposition temperature, Tdec, and glass 
transition temperature, Tg of API-ILs in study 
API- ILs designation Tm / K Tdec / K Tg / K 
Cholinium nalidixate 
349.22 434.14 256.34 
Cholinium niflumate 
268.45 461.62 253.70 
Cholinium pyrazinate 
354.46 452.56 226.00 
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One of the major problems in pharmaceutical industry has been attributed to 
physical properties of APIs. Most of APIs are marketed in solid state, however, there 
are some disadvantages related to this kind of formulation. The conversion of these 
APIs to a liquid formulation could be a great step to pharmaceutical industry(Ferraz et 
al. 2011; Hough et al. 2007). 
In Table 3.3, thermal properties of API-ILs formulations are summarized and it 
is possible conclude that the presence of cholinium cation directly influences the 
thermal stability of compounds, once that all compounds had approximately the same 
temperature of decomposition, 400K. 
The major advantage for thermal properties in incorporating cholinium cation 
with APIs is related to the decrease in melting temperature, Figure 3.1, in comparison to 
the parents APIs. All melting points decrease bellows 373.15 K, and the major decrease 
was verified for cholinium niflumate that are now liquid at room temperature. 
Besides cholinium pyrazinate have a higher melting point than room and body 
temperature, this API-IL remains liquid upon cooling until it reaches a glass transition 
at low temperature, 226.00 K. Upon heating above glass transition, had an exothermic 
crystallization peak (294.19 K), cold crystallization temperature, followed by an 
endothermic melting peak at 354.46 K. Thus, depending on the cooling-heating cycles 
this compound can be easily handled as liquid at room temperature. This represents an 
advantage to development of new drug delivery systems (Araújo et al. 2014). 
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3.4.2.In vitro cytotoxicity assays 
Biomedical application of API-ILs requires cytotoxicity measurements, in order 
to establish the biocompatibility of compounds in the organism. The aim of this study is 
to evaluate the impact of cholinium based APIs in comparison with parent APIs in cell 
lines mentioned above at different ranges of concentrations. Figure 3.2, Figure 3.3 and 
Figure 3.4 illustrates the cellular viability of the three parents APIs and API-ILs in 
study, in both cell lines.The range of study concentration varied from 10 μM to 6000 
μM depending of the compound. All tested concentrations are in accordance with 
pharmacokinetic parameter maximum plasma concentration of the parent APIs, which is 
above possible intracellular concentrations. For nalixidic acid and cholinium nalixidate, 
Figure 3.2, the tested concentration varied from 20 μM to 57.5 μM.  
Nevertheless, the maximum plasma range of concentrations accepted for 
nalidixic acid is between 53.82 μM and 61.58 μM.  
For niflumic acid and cholinium niflumate, Figure 3.3, the tested concentrations 
varied from 10 μM to 35 μM. Nevertheless, the maximum plasma range of 
concentrations accepted for niflumic acid is between 20.25 μM and 25.16 μM. 
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Figure 3.2 – Cellular viability for nalidixic acid and 
cholinium nalidixate in Caco-2 and HepG2 cell lines 
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Finally, for pyrazinoic acid and cholinium pyrazinate, the tested concentrations 
varied from 500 μM to 6000 μM (Figure 3.4). Nevertheless, the maximum plasma 
range of concentrations accepted for pyrazinoic acid is between 170.03 μM and 202.26 
μM. 
 
The cellular viability for both cell lines does not change significantly. Values of 
cellular viability in all concentrations for both APIs and API-ILs are around 100%. 
Sometimes higher values than 100% were achived due to the hormetic response, 
characterized by low-dose stimulation and a high-dose inhibition in the presence of the 
test compound (Calabrese and Baldwin 2003) Figure 3.2, 3.3 and 3.4). Cholinium is an  
essential nutrient presents in diverse functions of organism then it was supposed to have 
a high biocompatibility in human cell lines. (refseddo). This result confirms the 
behaviour that was expectable due to the nature of cholinium. Thereby no cytotoxicity 
was detected, as also none significance difference was observed in the metabolic 
activity of cells due to the incorporation of cholinium cation.  
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In conclusion, the design of API-ILs formulations does not show 
biocompatibility problems in comparison to the classical approach of APIs. 
 
3.4.3.Octanol-water partition coefficients 
 
The partition of active pharmaceutical principles represents the trend of the 
chemical to keep in circulation or passes through cells membranes. According to the 
mentioned in introduction and experimental procedure sections, the concentrations of 
APIs and API-ILs in water and octanol were measured to determine the affinity of the 
test compound to cross the cell membrane. Cholinium were described as a benign and 
high hydrophilic cation (Petkovic et al.2011)  and the addition of cholinium to parent 
APIs greatly increases the solubility of these compounds (Araújo et al., 2014).In this 
work, it was essential to evaluate if the addition of cholinium could interfere with the 
partition of APIs. In Table.3.4, the concentration of APIs and API-ILs in water phase is 
shown, as also the respective Kow values. In Figure 3.5, is represented the average of 
Kow values for both compounds, parent APIs and API-ILs. The uncertainty of the 
quantitive method was around 1% and the uncertainty of Kow values are 10%. This last 
value like was mentioned in Section 2.3.1 could be related to diverse factor like the 
variation in room temperature, the different solubilities between octanol and water at 
room Moreover, octanol and water form an emulsion that could lead to error in Kow 
measurements (Ropel et al.,2005).   
Table3.4 – Kow values and concentration of compound in water phase 
API Kow 
Concentration range in 
water phase/g L
-1 
Nalidixic acid 2.39 2.3 10
-3
-4.9 10
-3 
Niflumic acid 9.77-11.2 1.1 10
-3
-1.4 10
-3 
Pyrazinoic Acid 0.344 6.6 10
-3
-1.4 10
-2
 
API- ILs designation Kow 
Concentration range in 
water phase/g L
-1 
Cholinium nalidixate 2.18 2.3 10
-3
-4.8 10
-3
 
Cholinium niflumate 4.13-7.32 1.4 10
-3
-1.7 10
-3
 
Cholinium pyrazinate 0.20-0.32 1.0 10
-3
-1.1 10
-3
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To niflumic acid, cholinium niflumate and cholinium pyrazinate the Kow value 
are dependent of concentration. Furthermore, Figure 3.5 illustrates the differences 
between Kow values with parent APIs and API-ILs. These results suggest that no 
significant changes occur with this new approach.  
 
Taking into account the increment in solubility and the changes no significant in 
partition properties with addition of cholinium (Araújo et al., 2014) , it was possible to 
conclude that there will be an increasing of bioavailability of these compounds. 
 
3.5.Conclusion 
Finally is possible to conclude that this new cholinium based ILs approach with 
active pharmaceutical anions (nalidixic acid, niflumic acid and pyrazinoic acid) could 
effectively improve the solubility of parents APIs without affect cytotoxicity and 
penetrance into cell membranes, reducing the major problems in pharmaceuticals 
manufacturing. Additionally the low cost of cholinium cation and their own properties 
(biocompatibility, low toxicity and high water solubility) make this new design strategy 
a great opportunity to pharmaceutical industry to reuse some chemicals previous 
rejected during development process and turn the acceptance of novel APIs candidates 
easily.  
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4.1 General Conclusion 
This work is initially part of a project FCT: PTDC/EQU – FTT/118800/2010 
focused on the development of a new and improved generation of artificial blood 
substitutes containing fluorinated ionic liquids. However due to the collaborations 
opportunities in Thermodynamics laboratory there was the possibility to evaluate other 
pharmaceutical opportunities using ionic liquids, namely cholinium based API-ILs.  
The overall of the work is to evaluate thermophysical properties, toxicity 
profiles and octanol-water partition coefficients of some FILs. Besides, the comparison 
between parent APIs and cholinium based APIs were also achieved for the same 
properties mentioned before. 
Take into account the first part of the work, the FILs who better accomplish the 
characteristics of a blood substitute, conjugating all the results of thermophysical 
properties, cytotoxicity and partition properties were  [EtMeIm][(PFBu)SO3], 
[EtMepy][(PFBu)SO3] and [NM3(EtOH)][(PFBu)SO3]. 
Finally, it was also possible to conclude that the formulation of API-ILs with the 
cholinium cation represent an advantage for pharmaceutical research. Once that API-ILs 
present a higher solubility in water than APIs and the toxicity and the partition for cell 
membranes does not alter. With a higher solubility and the same partition the 
bioavailability of the original compouns increase a lot. 
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4.2 Future Work 
Fortunately the numerous applications for ionic liquids make this area very 
attractive for different search fields and future work will always be innovative. 
As future work and in order to continue our project some FILs recently 
synthetized should also be characterized for these properties (thermophysical properties, 
cytotoxicity and bioavailability). The results obtained in this work will help in the 
design of the most suitable FILs for application in artificial blood substitutes and had a 
great importance also in a fundamental research as in an application level. 
Firstly and to evaluate the partition properties of FILs without aromatic ring the 
HPLC technique will be optimized. Some toxicity tests will be done to understand the 
mechanism involved in cellular death. 
After select the FIL to incorporate in current PFCs emulsions all the tests made 
until now should also be done, in order to evaluate the systems behaviour, to discard 
some possible side effects of the mixture. 
The development of this new cholinium based ILs give the opportunity too many 
pharmaceutical discarded by lack of solubility came to the market. The evaluation of 
more possible combination and the formulations of new API-ILs that improve the 
characteristics of pattern drugs are also in our pipeline. 
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Table A.1 - Chemical structure and respective abbreviation of fluorinated ionic liquids 
in literature (Cortes, 2013; Pereiro et al., 2013) 
FIL Designation Chemical Structure 
Tetrabutylammonium 
perfluorobutanesulfonate 
[NBu4][(PFBu)SO3]  
1-Ethyl-3-methylpyridinium 
perfluobutanesulfonate 
[EtMepy][(PFBu)SO3] 
 
1-Mehtyl-3-octylimidazolium 
perfluorobutanesulfonate 
[OcMeIm][(PFBu)SO3]  
1-Hexyl-3-methylimidazolium 
perfluorobutanesulfonate 
[HexMeIm][(PFBu)SO3]  
1-Butyl-1-methylpyrrolidinum 
perfluorobutanesulfonate 
[BuMepyr][(PFBu)SO3] 
 
1-Ethyl-3methylimidazolium 
perfluorobutanesulfonate 
[EtMeIm][(PFBu)SO3] 
 
1-Butyl-N-methylpyrrolidinium 
bis(nonafluorobutylsulfonyl)imide 
[BuMepyr][NNf2] 
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